<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Parkinsons Dis</journal-id><journal-id journal-id-type="iso-abbrev">Parkinsons Dis</journal-id><journal-id journal-id-type="publisher-id">PD</journal-id><journal-title-group><journal-title>Parkinson's Disease</journal-title></journal-title-group><issn pub-type="ppub">2090-8083</issn><issn pub-type="epub">2042-0080</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5525082</article-id><article-id pub-id-type="doi">10.1155/2017/4318416</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2095-3197</contrib-id><name><surname>Camp&#x000ea;lo</surname><given-names>Clarissa Loureiro das Chagas</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9017-3922</contrib-id><name><surname>Silva</surname><given-names>Regina Helena</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Memory Studies Laboratory, Department of Physiology, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil</aff><aff id="I2">
<sup>2</sup>Behavioral Neuroscience Laboratory, Department of Pharmacology, Universidade Federal de S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil</aff><author-notes><corresp id="cor1">*Regina Helena Silva: <email>reginahsilva@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Hao Deng</p></fn></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>11</day><month>7</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>4318416</elocation-id><history><date date-type="received"><day>13</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>17</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>24</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Clarissa Loureiro das Chagas Camp&#x000ea;lo and Regina Helena Silva.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>There is increasing evidence of the contribution of genetic susceptibility to the etiology of Parkinson's disease (PD). Genetic variations in the SNCA gene are well established by linkage and genome-wide association studies. Positive associations of single nucleotide polymorphisms (SNPs) in SNCA and increased risk for PD were found. However, the role of SNCA variants in individual traits or phenotypes of PD is unknown. Here, we reviewed the current literature and identified 57 studies, performed in fourteen different countries, that investigated SNCA variants and susceptibility to PD. We discussed the findings based on environmental factors, history of PD, clinical outcomes, and ethnicity. In conclusion, SNPs within the SNCA gene can modify the susceptibility to PD, leading to increased or decreased risk. The risk associations of some SNPs varied among samples. Of notice, no studies in South American or African populations were found. There is little information about the effects of these variants on particular clinical aspects of PD, such as motor and nonmotor symptoms. Similarly, evidence of possible interactions between SNCA SNPs and environmental factors or disease progression is scarce. There is a need to expand the clinical applicability of these data as well as to investigate the role of SNCA SNPs in populations with different ethnic backgrounds.</p></abstract><funding-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico</funding-source><award-id>402054/2010-5</award-id></award-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior</funding-source></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Apoio &#x000e0; Pesquisa do Estado do Rio Grande do Norte</funding-source></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</funding-source><award-id>2015/12308-5</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Parkinson's disease (PD) is a neurodegenerative disorder that is characterized by motor dysfunction but also causes nonmotor deficits [<xref rid="B1" ref-type="bibr">1</xref>]. Although the etiology of PD remains unclear, the interaction between genetic and environmental factors has been implicated in the emergence of the disease [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>]. Genome-wide association studies (GWAS) have identified variants of many candidate genes that contribute to PD susceptibility, such as variations of the SNCA gene [<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>]. Moreover, certain polymorphisms of SNCA are among the major risk factors for sporadic PD [<xref rid="B5" ref-type="bibr">5</xref>].</p><p>The SNCA gene is located on human chromosome 4 and encodes the protein alpha-synuclein. The physiological function of alpha-synuclein is not completely understood. Studies have shown a key role for alpha-synuclein in the regulation of neurotransmitter release, synaptic function, and plasticity of dopaminergic neurons [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>]. The involvement in dopaminergic transmission and the predominant presence of alpha-synuclein in Lewy bodies [<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B12" ref-type="bibr">12</xref>] denote the relationship of this protein with the etiology of PD. In addition, genetic data support the role of alpha-synuclein in the pathogenic process of the disease. For example, missense mutations in SNCA locus were identified in familial forms of PD (A53T, A30P, E46K, and H50Q) [<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>], as well as in sporadic PD patients (A18T and A29S) [<xref rid="B18" ref-type="bibr">18</xref>]. Further, duplications and triplications of the SNCA locus cause familial parkinsonism and correlate with disease severity [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p><p>Single nucleotide polymorphism (SNP) analyses in case-control studies performed in different populations have shown an association between several SNCA polymorphisms and the risk of PD. For example, the dinucleotide repeat REP1 located in the SNCA promoter (SNCA-REP1) and the 3&#x02032; untranslated region (UTR) variants are frequently investigated [<xref rid="B21" ref-type="bibr">21</xref>]. Variations in these regions may increase susceptibility to PD by interfering with transcription factor binding sites [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>] and creating or destroying microRNAs target sites, which in turn modifies gene expression [<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>].</p><p>In spite of the fact that this type of study is frequent, investigations of the association between SNPs and the risk of PD in different populations show conflicting results. Furthermore, the consequences of genetic variability on clinical phenotypes, as well the interaction between genetic and environmental substrates, are poorly elucidated. Ideally, data from SNP studies would improve knowledge of pathophysiological pathways and help to target the best therapeutic program. This review aims to identify and compare the main SNP association studies conducted in different populations. The role of SNCA polymorphisms as a risk factor for PD and their association with clinical outcomes are discussed.</p></sec><sec id="sec2"><title>2. Literature Search</title><p>We conducted a survey in the relevant databases PubMed/Medline and Scopus for studies up to July 2016 using combinations of the keywords &#x0201c;polymorphism&#x0201d;, &#x0201c;alpha synuclein&#x0201d;, &#x0201c;SNCA gene&#x0201d;, and &#x0201c;Parkinson's disease&#x0201d;. We selected articles that met the following inclusion criteria: (a) articles that are written in English; (b) articles that described investigations of SNPs in the SNCA gene; (c) articles that had available data of allele and genotype distributions; (d) studies that were conducted in humans; (e) studies including participants who were diagnosed with Parkinson's disease. 57 studies were selected to conduct the review. In addition, despite not necessarily meeting the selection criteria, other relevant publications were included throughout the article in order to foment discussion.</p><p>The following information was extracted from each study: authors, year of publication, country of the studied population, number of patients and control subjects, risk association with PD, and investigation of environmental factors and clinical outcomes. The association of SNCA polymorphisms and PD susceptibility was often assessed by comparing the frequency of risk allele and risk genotypes in patients and controls. Values of odds ratio (OR) and confidence interval (95% CI) indicated the characteristic and significance of the association (OR values higher than 1 indicated increased risk and values lower than 1 suggested reduced risk).</p><p>
<xref ref-type="table" rid="tab1">Table 1</xref> summarizes the main data from the 57 selected studies. The majority of the studies were performed in Caucasian and Asian populations. The studies were carried out in fourteen different countries (Mexico, China, Russia, Germany, Taiwan, USA, Japan, Spain, Italy, Ireland, Netherlands, Norway, Australia, and Greece) assembling patients from twenty countries (Mexico, China, Russia, Germany, Taiwan, USA, Japan, Spain, Italy, Norway, Netherlands, Serbia, Ireland, Australia, France, Greece, Poland, Sweden, Iran, and Australia). Sample sizes varied from 91 to 5302 patients in PD groups. The mean age at onset of PD varied from 45.2 to 68.2 years old.</p></sec><sec id="sec3"><title>3. SNPs and the Risk for Parkinson's Disease</title><p>GWAS have identified 28 distinct loci that modify the individual risk to PD [<xref rid="B84" ref-type="bibr">85</xref>] and suggest that genetic factors contribute to at least one-fourth of the total variation in liability to PD [<xref rid="B85" ref-type="bibr">86</xref>]. The two most consistent genes for susceptibility to sporadic PD are the alpha-synuclein (SNCA) and microtubule-associated protein tau (MAPT) genes, which can exert independent or joint effects on the risk of PD [<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B86" ref-type="bibr">87</xref>]. In addition, variants in other genes previously linked with autosomal forms (LRRK2, PARK16&#x02013;18, and GBA) have also shown association with PD risk [<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B87" ref-type="bibr">88</xref>&#x02013;<xref rid="B89" ref-type="bibr">90</xref>]. Based on odds ratio and confidence intervals values in the selected studies, thirty-nine different SNPs in the SNCA gene showed a statistically significant effect on PD susceptibility: nine variants in the 5&#x02032; end, nine variants near the 3&#x02032; end, and 25 intron variants (<xref ref-type="table" rid="tab2">Table 2</xref>). The locations of the six more frequently investigated SNPs within the SNCA gene are illustrated in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>Two major linkage disequilibrium blocks in the SNCA gene have been proposed: (1) a 5&#x02032; block that extends from the promoter-enhancer region to exon 4 and (2) a 3&#x02032; block that includes intron 4, 3&#x02032; UTR, and the 3&#x02032; end region of the gene [<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B80" ref-type="bibr">80</xref>]. SNPs in the 3&#x02032; block presented a more expressive association with PD. The largest number of significant markers in the 3&#x02032; block across different populations suggests a major causal effect for variants located in the 3&#x02032; end compared with the 5&#x02032; end. The 3&#x02032; block contains elements with higher conservation across species, which emphasize its biological relevance [<xref rid="B25" ref-type="bibr">25</xref>].</p><p>The polymorphic microsatellite REP1 (D4S3481) in the promoter region of SNCA is one of the most frequently investigated polymorphisms and was pointed out as a risk factor in thirteen of the articles [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B81" ref-type="bibr">81</xref>]. REP1 region plays a crucial role in the regulation of alpha-synuclein protein expression. Variants in REP1 are the only putative functional polymorphism identified within the SNCA locus. The REP1 SNP is a triallelic polymorphism with the longest (263&#x02009;bp) and intermediate length (261&#x02009;bp) alleles usually associated with an increased risk for PD, as seen in studies with North American [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B81" ref-type="bibr">81</xref>], German [<xref rid="B73" ref-type="bibr">73</xref>], Greek [<xref rid="B79" ref-type="bibr">79</xref>], and Dutch [<xref rid="B77" ref-type="bibr">77</xref>] samples. In 2006, a meta-analysis including over 5000 subjects provided strong evidence that the 263&#x02009;bp allele was more frequent in cases and that the 259&#x02009;bp allele was more frequent in controls (indicating decreased risk of PD) [<xref rid="B91" ref-type="bibr">91</xref>]. The other four SNPs in the 5&#x02032; region (rs2619362, rs2619363, rs2619364, and rs2583988) contributed to the increase in the risk of PD in North American [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B65" ref-type="bibr">65</xref>] and European [<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B77" ref-type="bibr">77</xref>] populations.</p><p>Twenty-five intronic variants were associated with PD susceptibility, although the precise function of those variants of human SNCA is still unknown. The SNP rs2736990 in intron 4 was the most frequent, with the exception of one study [<xref rid="B40" ref-type="bibr">40</xref>]; this SNP was a consistent risk factor for PD [<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B55" ref-type="bibr">55</xref>]. Similarly, the SNPs rs2572324, rs7684318, and rs894278 also increased susceptibility to sporadic PD [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>]. In contrast, a significant reduction of PD risk was found for the SNP rs356186 in Italian [<xref rid="B56" ref-type="bibr">56</xref>], North American [<xref rid="B60" ref-type="bibr">60</xref>], and Irish [<xref rid="B61" ref-type="bibr">61</xref>] samples.</p><p>Recently, the SNPs located near the 3&#x02032; end have also been identified as risk factors for PD. Within the 3&#x02032; region, the majority of the studies focused on rs356219, rs11931074, and rs356165. Among them, the SNP rs356219 was the most investigated, and it stands out as a consistent risk factor for PD in twelve of the studies. Variants in the 3&#x02032; region possibly increase SNCA expression because of the misregulation of the posttranscriptional control. In the 3&#x02032; untranslated region (UTR), there are target binding sites for two microRNAs (mir-7 and mir-153), and alterations in these regions might affect mRNA stability and translation [<xref rid="B92" ref-type="bibr">92</xref>]. Further, mir-7 and mir-153 were associated with SNCA mRNA expression in human studies [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>]. The SNP rs356219 showed a robust association as a common susceptibility marker in twelve studies with patients from Russia [<xref rid="B44" ref-type="bibr">44</xref>], Germany [<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B80" ref-type="bibr">80</xref>], Spain [<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>], Japan [<xref rid="B52" ref-type="bibr">52</xref>], China [<xref rid="B53" ref-type="bibr">53</xref>], USA [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B65" ref-type="bibr">65</xref>], United Kingdom [<xref rid="B78" ref-type="bibr">78</xref>], and Netherlands [<xref rid="B73" ref-type="bibr">73</xref>]. Similarly, the SNP rs11931074 showed a significant association with increased PD risk in seven studies, four of which were performed in Chinese samples [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>].</p><p>The variants rs356221, rs356165, and rs356182 in 3&#x02032; UTR also contribute significantly to the increase in the PD risk in Germany [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B80" ref-type="bibr">80</xref>], USA [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B50" ref-type="bibr">50</xref>], China [<xref rid="B34" ref-type="bibr">34</xref>], Taiwan [<xref rid="B45" ref-type="bibr">45</xref>], and Netherlands [<xref rid="B73" ref-type="bibr">73</xref>]. These findings reinforce the role of a posttranscriptional mechanism in PD etiology. The variant rs356165 was the most expressive [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B80" ref-type="bibr">80</xref>].</p></sec><sec id="sec4"><title>4. SNCA SNPs and Environmental Factors Interactions</title><p>Despite the relevance of environmental data to the understanding of the etiology of PD, the majority of studies contain little or no information on possible associations between SNCA SNPs and environmental factors (<xref ref-type="table" rid="tab3">Table 3</xref>).</p><p>Sporadic PD is considered a result of complex interactions between genetic and environmental risk factors. Professional pesticide exposure, rural living, and well-water drinking were reported to increase the risk of PD [<xref rid="B93" ref-type="bibr">93</xref>&#x02013;<xref rid="B95" ref-type="bibr">95</xref>]. In contrast, cigarette smoking [<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>] and caffeine intake [<xref rid="B98" ref-type="bibr">98</xref>] have been pointed out as protective factors. Furthermore, though less consistently, reduced PD risk was associated with alcohol drinking [<xref rid="B99" ref-type="bibr">99</xref>]. Potential interactions between SNCA SNPs and pesticide exposure, smoking habits, head injury, or coffee and alcohol drinking were investigated in a few of the studies [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>]. Overall, data demonstrated some pairwise interactions, but without reaching significant levels after Bonferroni correction. For example, although Miyake et al. [<xref rid="B52" ref-type="bibr">52</xref>], Chung et al. [<xref rid="B47" ref-type="bibr">47</xref>], and Gao et al. [<xref rid="B55" ref-type="bibr">55</xref>] found a significant protective effect of smoking habits against PD, corroborating epidemiological data, only the first study found significant interactions between SNPs rs356219 and rs356220 and smoking.</p><p>Meta-analyses [<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>] have reinforced the inverse association between cigarette smoking and PD risk more consistently than other environmental factors (rural living, well-water consumption, farming, and the use of pesticides). One of the mechanisms suggested to underlie this neuroprotection is the reduction of brain levels of the enzyme monoamine oxidase B (MAO B), an isoform that selectively metabolizes dopamine. This reduction would enhance the levels of dopamine and decrease the production of hydrogen peroxide and oxidative stress rates [<xref rid="B100" ref-type="bibr">100</xref>]. An alternative explanation is that smoke induces cytochrome P-450 enzyme activity. This enzyme is responsible for the metabolism of antipsychotic drugs and the detoxification of certain environmental toxins such as MPTP [<xref rid="B101" ref-type="bibr">101</xref>]. In this respect, a case-control study carried out in European countries investigated polymorphisms with relevance to brain expression and metabolism of substances contained in tobacco smoke and confirmed significant interactions of SNPs in cytochrome P-450 enzyme family genes (GSTM1, GSTP1, and NAT2). However, there is no information about the mechanisms that explain the biological interaction between SNCA genotypes and cigarette smoking.</p></sec><sec id="sec5"><title>5. SNCA SNPs and PD Clinical Outcomes Interactions</title><p>The influence of polymorphisms on PD phenotypic variability remains unclear. Indeed, few studies specifically investigated their associations with particular aspects of the disease, such as disease history and clinical outcomes (<xref ref-type="table" rid="tab4">Table 4</xref>).</p><p>The age at onset is the most frequently investigated and well established aspect of disease history. Polymorphisms located in the promoter (REP1), introns (rs2736990, rs894278), and 3&#x02032; region (rs356219 and rs356165) are suggested to be predictors of earlier PD onset in Australian and Chinese [<xref rid="B35" ref-type="bibr">35</xref>], Spanish [<xref rid="B54" ref-type="bibr">54</xref>], German [<xref rid="B46" ref-type="bibr">46</xref>], and UK [<xref rid="B61" ref-type="bibr">61</xref>] samples. The identification of genetic features associated with the onset of PD has a relevant potential for therapeutic targeting. In view of the fact that neurodegeneration precedes the appearance of motor symptoms [<xref rid="B102" ref-type="bibr">102</xref>], it is critical to predict the risk of developing PD prior to clinical manifestations.</p><p>Even though it is expected that SNCA variants would influence individual traits or phenotypes of sporadic PD, this association was poorly explored in the studies. In a longitudinal study with a North American sample, Ritz et al. [<xref rid="B50" ref-type="bibr">50</xref>] showed that the REP1-263&#x02009;bp promoter variant and the G-rs356165 allele are risk factors to faster motor progression in Caucasian and non-Caucasian PD patients (OR 1.66; 95% CI: 0.96&#x02013;2.88). Wang et al. [<xref rid="B31" ref-type="bibr">31</xref>] found a protective association between T-rs11931074 allele and motor severity. However, in a larger sample of Caucasian patients, Markopoulou et al. [<xref rid="B43" ref-type="bibr">43</xref>] showed that REP1-263&#x02009;pb allele reduced the risk of developing motor impairments. This divergence can be a result of differences in the methods of motor evaluation. According to Markopoulou et al. [<xref rid="B43" ref-type="bibr">43</xref>], the discrepancies may also suggest a dual and time-dependent role of SNCA.</p><p>Impairments in the olfactory function are a common early-stage nonmotor feature of PD, and the TT-rs11931074 genotype may increase the risk of hyposmia in PD cases [<xref rid="B34" ref-type="bibr">34</xref>].</p><p>Few other studies pointed out weak or absent associations with clinical outcomes such as anxiety or depression [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B74" ref-type="bibr">74</xref>], sleep and autonomic disorders [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B74" ref-type="bibr">74</xref>], and cognitive impairments [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B74" ref-type="bibr">74</xref>]. Regarding cognitive features, Markopoulou et al. [<xref rid="B43" ref-type="bibr">43</xref>] demonstrated that the REP1-259&#x02009;pb allele increased the risk of cognitive outcomes. Trotta et al. [<xref rid="B56" ref-type="bibr">56</xref>] found significant associations of C-rs10018362, T-rs7689942, and G-rs1348224 alleles with PD with dementia and also identified a specific haplotype in intron 4 of SNCA (C-rs62306323 and T-rs7689942) associated with increased risk of PD with dementia. It is important to mention that limited data of SNP associations with PD phenotype in cross-sectional studies might be related to a single event of clinical assessment, which could mask possible effects. Studies of such associations could provide important clinical applicability of the significant findings of genotyping studies. More studies evaluating specific clinical aspects, especially with longitudinal designs, are necessary to enhance the understanding of how genetic factors contribute to PD.</p></sec><sec id="sec6"><title>6. Biological Effects of SNCA SNPs</title><p>There is increasing evidence supporting the biological effects of genetic variants in SNCA, possibly by modifying alpha-synuclein expression. Among the studies listed in <xref ref-type="table" rid="tab5">Table 5</xref>, the associations of SNCA-REP1 and 3&#x02032; variants (rs356219 and 11931074) and peripheral alpha-synuclein levels were investigated in Chinese [<xref rid="B57" ref-type="bibr">57</xref>] and North American [<xref rid="B65" ref-type="bibr">65</xref>] populations. Mata et al. [<xref rid="B65" ref-type="bibr">65</xref>] found an association of CC-356219 genotype with increased plasma levels of alpha-synuclein. A variation in the REP1 region might affect transcriptional activity by increasing the expression of alpha-synuclein and consequent protein accumulation [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. SNCA duplication and triplication in familial PD have been linked to increased mRNA expression levels [<xref rid="B103" ref-type="bibr">103</xref>] and to disease severity [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p><p>In postmortem brain tissue studies, the 3&#x02032; region SNPs rs356219 [<xref rid="B104" ref-type="bibr">84</xref>], rs356165 [<xref rid="B24" ref-type="bibr">24</xref>], and rs11931074 [<xref rid="B39" ref-type="bibr">39</xref>] have been associated with increased gene expression. For rs356219, the heterozygote CT genotype correlated with higher levels of SNCA-mRNA in the substantia nigra of PD patients. However, the TT protective genotype was accompanied by higher expression in the cerebellum, a structure that is more preserved in the course of PD [<xref rid="B104" ref-type="bibr">84</xref>]. Similarly, G-rs356219 allele carriers presented higher levels of the SNCA112-mRNA isoform in the frontal cortex [<xref rid="B24" ref-type="bibr">24</xref>]. Further, PD patients presented higher levels of the SNCA-112 and SNCA-98 transcripts in the cerebellum and occipital cortex when compared to controls [<xref rid="B39" ref-type="bibr">39</xref>].</p><p>Linnertz et al. [<xref rid="B105" ref-type="bibr">104</xref>] investigated the effects of SNCA SNPs in 5&#x02032; and 3&#x02032; regions on SNCA expression in postmortem brains from neurologically normal subjects. For REP1, the 256&#x02009;bp/256&#x02009;bp genotype correlated with lower SNCA-mRNA levels, corroborating the hypotheses that decreased SNCA levels protect against the disease. Unexpectedly, the protective genotypes AA-rs356219 and AA-rs365165 in the 3&#x02032; region correlated with higher levels of SNCA-mRNA in the temporal cortex and substantia nigra, which highlights an expanded regulatory effect of this region on total SNCA-mRNA levels.</p><p>Regarding in vivo studies, patients with SNP rs2583988 genotypes did not present alterations in alpha-synuclein levels in peripheral blood mononuclear cells, while the protein levels were reduced in the absence of the REP1 risk allele [<xref rid="B104" ref-type="bibr">84</xref>]. For SNPs in the 3&#x02032; region, while carriers of T-rs11931074 allele presented reduced levels of protein in serum [<xref rid="B57" ref-type="bibr">57</xref>], a higher level of alpha-synuclein in plasma was observed in carriers of the C-rs356219 allele [<xref rid="B65" ref-type="bibr">65</xref>].</p></sec><sec id="sec7"><title>7. Genetical Background, Ethnicity, and the Effect of SNCA SNPs</title><p>Methodological aspects such as variations in the sample size, control of population stratification, and statistical analyses can explain the discrepancies in the effects of SNPs among the different studies. In addition, it is common to exclude the influence of confounder variables as sex, age, and ethnic background, which can modify the results substantially.</p><p>The majority of the studies were carried out in countries of Europe, North America, and Asia, that is, populations with mainly Caucasian and Asian genetic backgrounds. Despite the fact that ethnic differences can preclude the generalization of the results in genetic studies, many of the SNPs showed similar effects in groups with different genetic backgrounds. For example, the SNP rs356219 remained an important risk factor for PD in studies performed within North American [<xref rid="B65" ref-type="bibr">65</xref>], Spanish [<xref rid="B63" ref-type="bibr">63</xref>], Russian [<xref rid="B44" ref-type="bibr">44</xref>], and Chinese [<xref rid="B41" ref-type="bibr">41</xref>] populations. Nevertheless, given the significance of results and perspectives of clinical advancement, it seems necessary to extend these investigations to other continents, in order to confirm whether these genetic effects are consistent across different populations and to verify the implications of between-population heterogeneity.</p><p>Finally, apart from variants in the SNCA gene, it is necessary to consider the role of interactions between multiple genetic variants in disease risk and clinical profile. For example, investigations of phenotypic diversity in PD have identified an association between SNCA and MAPT. This association contributed to increased cognitive and motor severity in a Chinese sample [<xref rid="B31" ref-type="bibr">31</xref>] and influenced the development of cognitive impairment and dementia in a British sample [<xref rid="B78" ref-type="bibr">78</xref>]. In addition, polymorphisms in GAB [<xref rid="B28" ref-type="bibr">28</xref>] and LRRK2 [<xref rid="B58" ref-type="bibr">58</xref>] have been associated with earlier age at the onset in a European-American population and in a Spanish sample, respectively. Also, in North Americans, APOE variants predicted lower cognitive performance in PD patients [<xref rid="B42" ref-type="bibr">42</xref>].</p></sec><sec id="sec8"><title>8. Conclusions</title><p>This review collected the contributions of polymorphisms in the SNCA gene to PD susceptibility and clinical phenotypes. In most of the studies, the influence of polymorphisms in multiple regions of SNCA gene was pointed out, such as the promoter region (REP1-SNCA), 3&#x02032; end (e.g., rs11931074 and rs356219), 3&#x02032; untranslated regions (e.g., rs356165), and introns (e.g., rs7684318, rs894278, and rs276990). In addition, we highlight that it is necessary to expand the clinical applicability of these data, as well as investigate the role of SNCA variations in populations with different ethnic backgrounds.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the funding agencies Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq) (Grant no. 402054/2010-5), Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES), Funda&#x000e7;&#x000e3;o de Apoio &#x000e0; Pesquisa do Estado do Rio Grande do Norte (FAPERN/PRONEX), and Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (FAPESP) (Grant no. 2015/12308-5).</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahn</surname><given-names>S.</given-names></name></person-group><article-title>Description of Parkinson's disease as a clinical syndrome</article-title><source><italic>Annals of the New York Academy of Sciences</italic></source><year>2003</year><volume>991</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-0038727936</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wirdefeldt</surname><given-names>K.</given-names></name><name><surname>Adami</surname><given-names>H.</given-names></name><name><surname>Cole</surname><given-names>P.</given-names></name><name><surname>Trichopoulos</surname><given-names>D.</given-names></name><name><surname>Mandel</surname><given-names>J.</given-names></name></person-group><article-title>Epidemiology and etiology of Parkinson's disease: a review of the evidence</article-title><source><italic>European Journal of Epidemiology</italic></source><year>2011</year><volume>26</volume><issue>1, supplement</issue><fpage>S1</fpage><lpage>S58</lpage><pub-id pub-id-type="doi">10.1007/s10654-011-9581-6</pub-id><pub-id pub-id-type="other">2-s2.0-79959728747</pub-id><pub-id pub-id-type="pmid">21626386</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lau</surname><given-names>L. M.</given-names></name><name><surname>Breteler</surname><given-names>M. M.</given-names></name></person-group><article-title>Epidemiology of Parkinson's disease</article-title><source><italic>The Lancet Neurology</italic></source><year>2006</year><volume>5</volume><issue>6</issue><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(06)70471-9</pub-id><pub-id pub-id-type="other">2-s2.0-33745919520</pub-id><pub-id pub-id-type="pmid">16713924</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satake</surname><given-names>W.</given-names></name><name><surname>Nakabayashi</surname><given-names>Y.</given-names></name><name><surname>Mizuta</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease</article-title><source><italic>Nature Genetics</italic></source><year>2009</year><volume>41</volume><issue>12</issue><fpage>1303</fpage><lpage>1307</lpage><pub-id pub-id-type="other">2-s2.0-70549084415</pub-id><pub-id pub-id-type="doi">10.1038/ng.485</pub-id><pub-id pub-id-type="pmid">19915576</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f3;n-S&#x000e1;nchez</surname><given-names>J.</given-names></name><name><surname>Schulte</surname><given-names>C.</given-names></name><name><surname>Bras</surname><given-names>J. M.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Gibbs Berg</surname><given-names>D.</given-names><suffix>Jr.</suffix></name><etal/></person-group><article-title>Genome-wide association study reveals genetic risk underlying Parkinsons disease</article-title><source><italic>Nature Genetics</italic></source><year>2009</year><volume>41</volume><fpage>1308</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">19915575</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Ioannidis</surname><given-names>J. P. A.</given-names></name><name><surname>Aasly</surname><given-names>J. O.</given-names></name><etal/></person-group><article-title>Large-scale replication and heterogeneity in Parkinson disease genetic loci</article-title><source><italic>Neurology</italic></source><year>2012</year><volume>79</volume><issue>7</issue><fpage>659</fpage><lpage>667</lpage><pub-id pub-id-type="other">2-s2.0-84865196862</pub-id><pub-id pub-id-type="doi">10.1212/WNL.0b013e318264e353</pub-id><pub-id pub-id-type="pmid">22786590</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lashuel</surname><given-names>H. A.</given-names></name><name><surname>Overk</surname><given-names>C. R.</given-names></name><name><surname>Oueslati</surname><given-names>A.</given-names></name><name><surname>Masliah</surname><given-names>E.</given-names></name></person-group><article-title>The many faces of <italic>&#x003b1;</italic>-synuclein: from structure and toxicity to therapeutic target</article-title><source><italic>Nature Reviews Neuroscience</italic></source><year>2013</year><volume>14</volume><issue>1</issue><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/nrn3406</pub-id><pub-id pub-id-type="other">2-s2.0-84871414210</pub-id><pub-id pub-id-type="pmid">23254192</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendor</surname><given-names>J.</given-names></name><name><surname>Logan</surname><given-names>T.</given-names></name><name><surname>Edwards</surname><given-names>R.</given-names></name></person-group><article-title>The function of <italic>&#x003b1;</italic>-synuclein</article-title><source><italic>Neuron</italic></source><year>2013</year><volume>79</volume><issue>6</issue><fpage>1044</fpage><lpage>1066</lpage><pub-id pub-id-type="other">2-s2.0-84884250340</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.004</pub-id><pub-id pub-id-type="pmid">24050397</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisbach</surname><given-names>S. E.</given-names></name><name><surname>Outeiro</surname><given-names>T. F.</given-names></name></person-group><article-title>Alpha-Synuclein and intracellular trafficking: Impact on the spreading of Parkinson's disease pathology</article-title><source><italic>Journal of Molecular Medicine</italic></source><year>2013</year><volume>91</volume><issue>6</issue><fpage>693</fpage><lpage>703</lpage><pub-id pub-id-type="other">2-s2.0-84878614977</pub-id><pub-id pub-id-type="doi">10.1007/s00109-013-1038-9</pub-id><pub-id pub-id-type="pmid">23616088</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Lee</surname><given-names>V. M.-Y.</given-names></name></person-group><article-title>Aggregation of neurofilament and <italic>&#x003b1;</italic>-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia</article-title><source><italic>Archives of Neurology</italic></source><year>1998</year><volume>55</volume><issue>2</issue><fpage>151</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1001/archneur.55.2.151</pub-id><pub-id pub-id-type="other">2-s2.0-0031910093</pub-id><pub-id pub-id-type="pmid">9482355</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>M. G.</given-names></name><name><surname>Schmidt</surname><given-names>M. L.</given-names></name><name><surname>Lee</surname><given-names>V. M.</given-names></name><name><surname>Trojanowski</surname><given-names>J. Q.</given-names></name><name><surname>Jakes</surname><given-names>R.</given-names></name><name><surname>Goedert</surname><given-names>M.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-synuclein in Lewy bodies</article-title><source><italic>Nature</italic></source><year>1997</year><volume>388</volume><issue>6645</issue><fpage>839</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1038/42166</pub-id><pub-id pub-id-type="other">2-s2.0-0030882856</pub-id><pub-id pub-id-type="pmid">9278044</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spillantini</surname><given-names>M. G.</given-names></name><name><surname>Crowther</surname><given-names>R. A.</given-names></name><name><surname>Jakes</surname><given-names>R.</given-names></name><name><surname>Hasegawa</surname><given-names>M.</given-names></name><name><surname>Goedert</surname><given-names>M.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1998</year><volume>95</volume><issue>11</issue><fpage>6469</fpage><lpage>6473</lpage><pub-id pub-id-type="other">2-s2.0-0032568534</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.11.6469</pub-id><pub-id pub-id-type="pmid">9600990</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalaf</surname><given-names>O.</given-names></name><name><surname>Fauvet</surname><given-names>B.</given-names></name><name><surname>Oueslati</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The H50Q mutation enhances <italic>&#x003b1;&#x003b1;</italic>-synuclein aggregation, secretion, and toxicity</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2014</year><volume>289</volume><issue>32</issue><fpage>21856</fpage><lpage>21876</lpage><pub-id pub-id-type="other">2-s2.0-84905852264</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M114.553297</pub-id><pub-id pub-id-type="pmid">24936070</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozi</surname><given-names>M.</given-names></name><name><surname>Papadimitriou</surname><given-names>D.</given-names></name><name><surname>Antonellou</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Genetic assessment of familial and early-onset Parkinson's disease in a Greek population</article-title><source><italic>European Journal of Neurology</italic></source><year>2014</year><volume>21</volume><issue>7</issue><fpage>963</fpage><lpage>968</lpage><pub-id pub-id-type="other">2-s2.0-84902257960</pub-id><pub-id pub-id-type="doi">10.1111/ene.12315</pub-id><pub-id pub-id-type="pmid">24313877</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>R.</given-names></name><name><surname>Kuhn</surname><given-names>W.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Ala30Pro mutation in the gene encoding <italic>&#x003b1;</italic>-synuclein in Parkinson's disease</article-title><source><italic>Nature Genetics</italic></source><year>1998</year><volume>18</volume><issue>2</issue><fpage>106</fpage><lpage>108</lpage><pub-id pub-id-type="other">2-s2.0-0031990490</pub-id><pub-id pub-id-type="doi">10.1038/ng0298-106</pub-id><pub-id pub-id-type="pmid">9462735</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polymeropoulos</surname><given-names>M. H.</given-names></name><name><surname>Lavedan</surname><given-names>C.</given-names></name><name><surname>Leroy</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Mutation in the <italic>&#x003b1;</italic>-synuclein gene identified in families with Parkinson's disease</article-title><source><italic>Science</italic></source><year>1997</year><volume>276</volume><issue>5321</issue><fpage>2045</fpage><lpage>2047</lpage><pub-id pub-id-type="other">2-s2.0-0030744876</pub-id><pub-id pub-id-type="doi">10.1126/science.276.5321.2045</pub-id><pub-id pub-id-type="pmid">9197268</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarranz</surname><given-names>J. J.</given-names></name><name><surname>Alegre</surname><given-names>J.</given-names></name><name><surname>G&#x000f3;mez-Esteban</surname><given-names>J. C.</given-names></name><etal/></person-group><article-title>The new mutation, E46K, of <italic>&#x003b1;</italic>-synuclein causes Parkinson and Lewy body dementia</article-title><source><italic>Annals of Neurology</italic></source><year>2004</year><volume>55</volume><issue>2</issue><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1002/ana.10795</pub-id><pub-id pub-id-type="other">2-s2.0-10744230149</pub-id><pub-id pub-id-type="pmid">14755719</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman-Zacharska</surname><given-names>D.</given-names></name><name><surname>Koziorowski</surname><given-names>D.</given-names></name><name><surname>Ross</surname><given-names>O. A.</given-names></name><etal/></person-group><article-title>Novel A18T and pA29S substitutions in <italic>&#x003b1;</italic>-synuclein may be associated with sporadic Parkinson's disease</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2013</year><volume>19</volume><issue>11</issue><fpage>1057</fpage><lpage>1060</lpage><pub-id pub-id-type="other">2-s2.0-84886587005</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.07.011</pub-id><pub-id pub-id-type="pmid">23916651</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>P.</given-names></name><name><surname>Bonnet</surname><given-names>A.-M.</given-names></name><name><surname>D&#x000e9;barges</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Causal relation between <italic>&#x003b1;</italic>-synuclein gene duplication and familial Parkinson's disease</article-title><source><italic>The Lancet</italic></source><year>2004</year><volume>364</volume><issue>9440</issue><fpage>1169</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(04)17104-3</pub-id><pub-id pub-id-type="other">2-s2.0-4644236043</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chartier-Harlin</surname><given-names>M.</given-names></name><name><surname>Kachergus</surname><given-names>J.</given-names></name><name><surname>Roumier</surname><given-names>C.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-synuclein locus duplication as a cause of familial Parkinson's disease</article-title><source><italic>The Lancet</italic></source><year>2004</year><volume>364</volume><issue>9440</issue><fpage>1167</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)17103-1</pub-id><pub-id pub-id-type="other">2-s2.0-4644290985</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pals</surname><given-names>P.</given-names></name><name><surname>Lincoln</surname><given-names>S.</given-names></name><name><surname>Manning</surname><given-names>J.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein promoter confers susceptibility to Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>2004</year><volume>56</volume><issue>4</issue><fpage>591</fpage><lpage>595</lpage><pub-id pub-id-type="other">2-s2.0-4844222408</pub-id><pub-id pub-id-type="doi">10.1002/ana.20268</pub-id><pub-id pub-id-type="pmid">15455394</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiba-Falek</surname><given-names>O.</given-names></name><name><surname>Nussbaum</surname><given-names>R. L.</given-names></name></person-group><article-title>Effect of allelic variation at the NACP-Rep1 repeat upstream of the <italic>&#x003b1;</italic>-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system</article-title><source><italic>Human Molecular Genetics</italic></source><year>2001</year><volume>10</volume><issue>26</issue><fpage>3101</fpage><lpage>3109</lpage><pub-id pub-id-type="other">2-s2.0-0035894661</pub-id><pub-id pub-id-type="doi">10.1093/hmg/10.26.3101</pub-id><pub-id pub-id-type="pmid">11751692</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chib-Falek</surname><given-names>O.</given-names></name><name><surname>Touchman</surname><given-names>J. W.</given-names></name><name><surname>Nussbaum</surname><given-names>R. L.</given-names></name></person-group><article-title>Functional analysis of intra-allelic variation at NACP-Rep1 in the <italic>&#x003b1;</italic>-synuclein gene</article-title><source><italic>Human Genetics</italic></source><year>2003</year><volume>113</volume><issue>5</issue><fpage>426</fpage><lpage>431</lpage><pub-id pub-id-type="other">2-s2.0-0142070814</pub-id><pub-id pub-id-type="doi">10.1007/s00439-003-1002-9</pub-id><pub-id pub-id-type="pmid">12923682</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>J. J.</given-names></name><name><surname>Linnertz</surname><given-names>C.</given-names></name><name><surname>Saucier</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The effect of SNCA 3&#x02032; region on the levels of SNCA-112 splicing variant</article-title><source><italic>Neurogenetics</italic></source><year>2011</year><volume>12</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="other">2-s2.0-79951549421</pub-id><pub-id pub-id-type="doi">10.1007/s10048-010-0263-4</pub-id><pub-id pub-id-type="pmid">21046180</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotiriou</surname><given-names>S.</given-names></name><name><surname>Gibney</surname><given-names>G.</given-names></name><name><surname>Baxevanis</surname><given-names>A. D.</given-names></name><name><surname>Nussbaum</surname><given-names>R. L.</given-names></name></person-group><article-title>A single nucleotide polymorphism in the 3&#x02032;UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease</article-title><source><italic>Neuroscience Letters</italic></source><year>2009</year><volume>461</volume><issue>2</issue><fpage>196</fpage><lpage>201</lpage><pub-id pub-id-type="other">2-s2.0-67649639645</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2009.06.034</pub-id><pub-id pub-id-type="pmid">19540308</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>van der Walt</surname><given-names>J. M.</given-names></name><name><surname>Mayhew</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of <italic>&#x003b1;</italic>-synuclein</article-title><source><italic>The American Journal of Human Genetics</italic></source><year>2008</year><volume>82</volume><issue>2</issue><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.021</pub-id><pub-id pub-id-type="other">2-s2.0-40749145370</pub-id><pub-id pub-id-type="pmid">18252210</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila-Ortiz de Montellano</surname><given-names>D. J.</given-names></name><name><surname>Rodriguez-Violante</surname><given-names>M.</given-names></name><name><surname>Fresan</surname><given-names>A.</given-names></name><name><surname>Monroy-Jaramillo</surname><given-names>N.</given-names></name><name><surname>Yescas-Gomez</surname><given-names>P.</given-names></name></person-group><article-title>Frequency of single nucleotide polymorphisms and alpha-synuclein haplotypes associated with sporadic Parkinsons disease in the Mexican population</article-title><source><italic>Revue Neurologique</italic></source><year>2016</year><volume>63</volume><fpage>345</fpage><lpage>350</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>A. A.</given-names></name><name><surname>Andruska</surname><given-names>K. M.</given-names></name><name><surname>Benitez</surname><given-names>B. A.</given-names></name><name><surname>Racette</surname><given-names>B. A.</given-names></name><name><surname>Perlmutter</surname><given-names>J. S.</given-names></name><name><surname>Cruchaga</surname><given-names>C.</given-names></name></person-group><article-title>Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression</article-title><source><italic>Neurobiology of Aging</italic></source><year>2016</year><volume>37</volume><fpage>209.e1</fpage><lpage>209.e7</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.09.014</pub-id><pub-id pub-id-type="other">2-s2.0-84951075844</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>S.</given-names></name><name><surname>Chavira-Hern&#x000e1;ndez</surname><given-names>G.</given-names></name><name><surname>Gallegos-Arreola</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The rs3857059 variant of the SNCA gene is associated with Parkinson&#x02019;s disease in Mexican Mestizos</article-title><source><italic>Arquivos de Neuro-Psiquiatria</italic></source><year>2016</year><volume>74</volume><issue>6</issue><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1590/0004-282x20160061</pub-id><pub-id pub-id-type="pmid">27332068</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahmohammadibeni</surname><given-names>N.</given-names></name><name><surname>Rahimi-Aliabadi</surname><given-names>S.</given-names></name><name><surname>Jamshidi</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The analysis of association between SNCA, HUSEYO and CSMD1 gene variants and Parkinson&#x02019;s disease in Iranian population</article-title><source><italic>Neurological Sciences</italic></source><year>2016</year><volume>37</volume><issue>5</issue><fpage>731</fpage><lpage>736</lpage><pub-id pub-id-type="other">2-s2.0-84953303593</pub-id><pub-id pub-id-type="doi">10.1007/s10072-015-2420-x</pub-id><pub-id pub-id-type="pmid">26732583</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Wei Chen</surname></name><etal/></person-group><article-title>Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2016</year><volume>24</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="other">2-s2.0-84958859535</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.12.018</pub-id><pub-id pub-id-type="pmid">26776090</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>N.-N.</given-names></name><etal/></person-group><article-title>SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese</article-title><source><italic>Journal of the Neurological Sciences</italic></source><year>2016</year><volume>368</volume><fpage>231</fpage><lpage>234</lpage><pub-id pub-id-type="other">2-s2.0-84978225987</pub-id><pub-id pub-id-type="doi">10.1016/j.jns.2016.07.032</pub-id><pub-id pub-id-type="pmid">27538639</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guella</surname><given-names>I.</given-names></name><name><surname>Evans</surname><given-names>D. M.</given-names></name><name><surname>Szu-Tu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-synuclein genetic variability: a biomarker for dementia in Parkinson disease</article-title><source><italic>Annals of Neurology</italic></source><year>2016</year><volume>79</volume><issue>6</issue><fpage>991</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1002/ana.24664</pub-id><pub-id pub-id-type="other">2-s2.0-84965123533</pub-id><pub-id pub-id-type="pmid">27091628</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Kang</surname><given-names>W.-Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2015</year><volume>21</volume><issue>6</issue><fpage>610</fpage><lpage>614</lpage><pub-id pub-id-type="other">2-s2.0-84929517439</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.03.021</pub-id><pub-id pub-id-type="pmid">25921825</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Rowe</surname><given-names>D.</given-names></name><etal/></person-group><article-title>SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians</article-title><source><italic>BioMed Research International</italic></source><year>2015</year><volume>2015</volume><pub-id pub-id-type="other">2-s2.0-84928975179</pub-id><pub-id pub-id-type="doi">10.1155/2015/135674</pub-id><pub-id pub-id-type="publisher-id">135674</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Mi</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Tian</surname><given-names>Q.</given-names></name></person-group><article-title>Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: a meta-analysis</article-title><source><italic>American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</italic></source><year>2015</year><volume>168</volume><issue>2</issue><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1002/ajmg.b.32288</pub-id><pub-id pub-id-type="other">2-s2.0-84923094443</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. P.</given-names></name><name><surname>Wei</surname><given-names>Q.-Q.</given-names></name><name><surname>Ou</surname><given-names>R. W.</given-names></name><etal/></person-group><article-title>Genetic variants of snca are associated with susceptibility to Parkinson's disease but not amyotrophic lateral sclerosis or multiple system atrophy in a Chinese population</article-title><source><italic>PLoS ONE</italic></source><year>2015</year><volume>10</volume><issue>7</issue><pub-id pub-id-type="other">2-s2.0-84941729968</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0133776</pub-id><pub-id pub-id-type="publisher-id">e0133776</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Zhao</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Head injury, potential interaction with genes, and risk for Parkinson's disease</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2015</year><volume>21</volume><issue>3</issue><fpage>292</fpage><lpage>296</lpage><pub-id pub-id-type="other">2-s2.0-84923224939</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2014.12.033</pub-id><pub-id pub-id-type="pmid">25603768</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardo</surname><given-names>L. F.</given-names></name><name><surname>Coto</surname><given-names>E.</given-names></name><name><surname>de Mena</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms</article-title><source><italic>Neuroscience Letters</italic></source><year>2014</year><volume>562</volume><fpage>45</fpage><lpage>49</lpage><pub-id pub-id-type="other">2-s2.0-84893425589</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2014.01.009</pub-id><pub-id pub-id-type="pmid">24418406</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X. Y.</given-names></name><name><surname>Chen</surname><given-names>Y. P.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><etal/></person-group><article-title>SNCA variants rs2736990 and rs356220 as risk factors for Parkinson's disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population</article-title><source><italic>Neurobiology of Aging</italic></source><year>2014</year><volume>35</volume><issue>12</issue><fpage>2882.e1</fpage><lpage>2882.e6</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.07.014</pub-id><pub-id pub-id-type="other">2-s2.0-84911375711</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>F.</given-names></name><name><surname>Ding</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Association of polymorphism in rs2736990 of the -synuclein gene with Parkinson&#x02032;s disease in a Chinese population</article-title><source><italic>Neurology India</italic></source><year>2013</year><volume>61</volume><issue>4</issue><fpage>360</fpage><lpage>364</lpage><pub-id pub-id-type="other">2-s2.0-84884605258</pub-id><pub-id pub-id-type="doi">10.4103/0028-3886.117595</pub-id><pub-id pub-id-type="pmid">24005725</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata</surname><given-names>I. F.</given-names></name><name><surname>Leverenz</surname><given-names>J. B.</given-names></name><name><surname>Weintraub</surname><given-names>D.</given-names></name><etal/></person-group><article-title>APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease</article-title><source><italic>JAMA Neurology</italic></source><year>2014</year><volume>71</volume><issue>11</issue><fpage>1405</fpage><lpage>1412</lpage><pub-id pub-id-type="other">2-s2.0-84908008615</pub-id><pub-id pub-id-type="doi">10.1001/jamaneurol.2014.1455</pub-id><pub-id pub-id-type="pmid">25178429</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markopoulou</surname><given-names>K.</given-names></name><name><surname>Biernacka</surname><given-names>J. M.</given-names></name><name><surname>Armasu</surname><given-names>S. M.</given-names></name><etal/></person-group><article-title>Does <italic>&#x003b1;</italic>-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2014</year><volume>20</volume><issue>6</issue><fpage>584</fpage><lpage>589</lpage><pub-id pub-id-type="other">2-s2.0-84899998015</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2014.02.021</pub-id><pub-id pub-id-type="pmid">24656894</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emelyanov</surname><given-names>A.</given-names></name><name><surname>Andoskin</surname><given-names>P.</given-names></name><name><surname>Yakimovskii</surname><given-names>A.</given-names></name><etal/></person-group><article-title>SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2013</year><volume>19</volume><issue>11</issue><fpage>1064</fpage><lpage>1065</lpage><pub-id pub-id-type="other">2-s2.0-84886582121</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.06.003</pub-id><pub-id pub-id-type="pmid">23830801</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu-Chou</surname><given-names>Y.-H.</given-names></name><name><surname>Chen</surname><given-names>Y.-T.</given-names></name><name><surname>Yeh</surname><given-names>T.-H.</given-names></name><etal/></person-group><article-title>Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2013</year><volume>19</volume><issue>2</issue><fpage>251</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.10.019</pub-id><pub-id pub-id-type="other">2-s2.0-84873719976</pub-id><pub-id pub-id-type="pmid">23182315</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockmann</surname><given-names>K.</given-names></name><name><surname>Schulte</surname><given-names>C.</given-names></name><name><surname>Hauser</surname><given-names>A.-K.</given-names></name><etal/></person-group><article-title>SNCA: major genetic modifier of age at onset of Parkinson's disease</article-title><source><italic>Movement Disorders</italic></source><year>2013</year><volume>28</volume><issue>9</issue><fpage>1217</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1002/mds.25469</pub-id><pub-id pub-id-type="other">2-s2.0-84883557700</pub-id><pub-id pub-id-type="pmid">23674386</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S. J.</given-names></name><name><surname>Armasu</surname><given-names>S. M.</given-names></name><name><surname>Anderson</surname><given-names>K. J.</given-names></name><etal/></person-group><article-title>Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2013</year><volume>19</volume><issue>6</issue><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.02.008</pub-id><pub-id pub-id-type="other">2-s2.0-84891537762</pub-id><pub-id pub-id-type="pmid">23507417</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pihlstr&#x000f8;m</surname><given-names>L.</given-names></name><name><surname>Axelsson</surname><given-names>G.</given-names></name><name><surname>Bj&#x000f8;rnar&#x000e5;</surname><given-names>K. A.</given-names></name><etal/></person-group><article-title>Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease</article-title><source><italic>Neurobiology of Aging</italic></source><year>2013</year><volume>34</volume><issue>6</issue><fpage>1708.e7</fpage><lpage>1708.e13</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.10.019</pub-id><pub-id pub-id-type="other">2-s2.0-84875257430</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckman</surname><given-names>M. G.</given-names></name><name><surname>Soto-Ortolaza</surname><given-names>A. I.</given-names></name><name><surname>Diehl</surname><given-names>N. N.</given-names></name><etal/></person-group><article-title>Evaluation of the role of SNCA variants in survival without neurological disease</article-title><source><italic>PLoS ONE</italic></source><year>2012</year><volume>7</volume><issue>8</issue><pub-id pub-id-type="other">2-s2.0-84865061143</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0042877</pub-id><pub-id pub-id-type="publisher-id">e42877</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname><given-names>B.</given-names></name><name><surname>Rhodes</surname><given-names>S. L.</given-names></name><name><surname>Bordelon</surname><given-names>Y.</given-names></name><name><surname>Bronstein</surname><given-names>J.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease</article-title><source><italic>PLoS ONE</italic></source><year>2012</year><volume>7</volume><issue>5</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0036199</pub-id><pub-id pub-id-type="publisher-id">e36199</pub-id><pub-id pub-id-type="other">2-s2.0-84866164284</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname><given-names>I.</given-names></name><name><surname>W&#x000fc;llner</surname><given-names>U.</given-names></name><name><surname>Van Rooyen</surname><given-names>J. P.</given-names></name><etal/></person-group><article-title>Variants in the 3&#x02032;UTR of SNCA do not affect miRNA-433 binding and alpha-synuclein expression</article-title><source><italic>European Journal of Human Genetics</italic></source><year>2012</year><volume>20</volume><issue>12</issue><fpage>1265</fpage><lpage>1269</lpage><pub-id pub-id-type="other">2-s2.0-84869228626</pub-id><pub-id pub-id-type="doi">10.1038/ejhg.2012.84</pub-id><pub-id pub-id-type="pmid">22617348</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>Y.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Fukushima</surname><given-names>W.</given-names></name><etal/></person-group><article-title>SNCA polymorphisms, smoking, and sporadic Parkinson's disease in Japanese</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2012</year><volume>18</volume><issue>5</issue><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.02.016</pub-id><pub-id pub-id-type="other">2-s2.0-84862831151</pub-id><pub-id pub-id-type="pmid">22425546</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>F.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Ding</surname><given-names>H.</given-names></name><etal/></person-group><article-title>SNP rs356219 of the <italic>&#x003b1;</italic>-synuclein (SNCA) gene is associated with Parkinson's disease in a Chinese Han population</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2012</year><volume>18</volume><issue>5</issue><fpage>632</fpage><lpage>634</lpage><pub-id pub-id-type="other">2-s2.0-84862820839</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.01.025</pub-id><pub-id pub-id-type="pmid">22349157</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardo</surname><given-names>L. F.</given-names></name><name><surname>Coto</surname><given-names>E.</given-names></name><name><surname>de Mena</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A search for SNCA 3&#x02032; UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease</article-title><source><italic>Journal of Molecular Neuroscience</italic></source><year>2012</year><volume>47</volume><issue>3</issue><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1007/s12031-011-9669-1</pub-id><pub-id pub-id-type="other">2-s2.0-84863860992</pub-id><pub-id pub-id-type="pmid">22076805</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Nalls</surname><given-names>M. A.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>An exploratory analysis on gene-environment interactions for Parkinson disease</article-title><source><italic>Neurobiology of Aging</italic></source><year>2012</year><volume>33</volume><issue>10</issue><fpage>2528.e1</fpage><lpage>2528.e6</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.06.007</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotta</surname><given-names>L.</given-names></name><name><surname>Guella</surname><given-names>I.</given-names></name><name><surname>Sold&#x000e0;</surname><given-names>G.</given-names></name><etal/></person-group><article-title>SNCA and MAPT genes: independent and joint effects in Parkinson disease in the Italian population</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2012</year><volume>18</volume><issue>3</issue><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2011.10.014</pub-id><pub-id pub-id-type="other">2-s2.0-84857442897</pub-id><pub-id pub-id-type="pmid">22104010</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Guo</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Variant in the 30 region of SNCA associated with Parkinson's disease and serum <italic>&#x003b1;</italic>-synuclein levels</article-title><source><italic>Journal of Neurology</italic></source><year>2012</year><volume>259</volume><issue>3</issue><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1007/s00415-011-6209-4</pub-id><pub-id pub-id-type="other">2-s2.0-84862583009</pub-id><pub-id pub-id-type="pmid">21853288</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botta-Orfila</surname><given-names>T.</given-names></name><name><surname>Ezquerra</surname><given-names>M.</given-names></name><name><surname>Pastor</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Age at onset in LRRK2-associated PD is modified by SNCA variants</article-title><source><italic>Journal of Molecular Neuroscience</italic></source><year>2012</year><volume>48</volume><issue>1</issue><fpage>245</fpage><lpage>247</lpage><pub-id pub-id-type="other">2-s2.0-84865107641</pub-id><pub-id pub-id-type="doi">10.1007/s12031-012-9820-7</pub-id><pub-id pub-id-type="pmid">22669510</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata</surname><given-names>I. F.</given-names></name><name><surname>Yearout</surname><given-names>D.</given-names></name><name><surname>Alvarez</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease</article-title><source><italic>Movement Disorders</italic></source><year>2011</year><volume>26</volume><issue>5</issue><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="other">2-s2.0-79955113404</pub-id><pub-id pub-id-type="doi">10.1002/mds.23642</pub-id><pub-id pub-id-type="pmid">21425343</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S. J.</given-names></name><name><surname>Armasu</surname><given-names>S. M.</given-names></name><name><surname>Biernacka</surname><given-names>J. M.</given-names></name><etal/></person-group><article-title>Common variants in PARK loci and related genes and Parkinson's disease</article-title><source><italic>Movement Disorders</italic></source><year>2011</year><volume>26</volume><issue>2</issue><fpage>280</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1002/mds.23376</pub-id><pub-id pub-id-type="other">2-s2.0-79951474478</pub-id><pub-id pub-id-type="pmid">21412835</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaz</surname><given-names>A.</given-names></name><name><surname>Ross</surname><given-names>O. A.</given-names></name><name><surname>Ioannidis</surname><given-names>J. P. A.</given-names></name><etal/></person-group><article-title>Independent and joint effects of the MAPT and SNCA genes in Parkinson disease</article-title><source><italic>Annals of Neurology</italic></source><year>2011</year><volume>69</volume><issue>5</issue><fpage>778</fpage><lpage>792</lpage><pub-id pub-id-type="other">2-s2.0-79955389000</pub-id><pub-id pub-id-type="doi">10.1002/ana.22321</pub-id><pub-id pub-id-type="pmid">21391235</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wider</surname><given-names>C.</given-names></name><name><surname>Vilari&#x000f1;o-G&#x000fc;ell</surname><given-names>C.</given-names></name><name><surname>Heckman</surname><given-names>M. G.</given-names></name><etal/></person-group><article-title>SNCA, MAPT, and GSK3B in Parkinson disease: A gene-gene interaction study</article-title><source><italic>European Journal of Neurology</italic></source><year>2011</year><volume>18</volume><issue>6</issue><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type="other">2-s2.0-79955741094</pub-id><pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03297.x</pub-id><pub-id pub-id-type="pmid">21159074</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botta-Orfila</surname><given-names>T.</given-names></name><name><surname>Ezquerra</surname><given-names>M.</given-names></name><name><surname>R&#x000ed;os</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease</article-title><source><italic>European Journal of Neurology</italic></source><year>2011</year><volume>18</volume><issue>3</issue><fpage>p. e32</fpage><pub-id pub-id-type="other">2-s2.0-79951643506</pub-id><pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03245.x</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biernacka</surname><given-names>J. M.</given-names></name><name><surname>Armasu</surname><given-names>S. M.</given-names></name><name><surname>Cunningham</surname><given-names>J. M.</given-names></name><name><surname>Eric Ahlskog</surname><given-names>J.</given-names></name><name><surname>Chung</surname><given-names>S. J.</given-names></name><name><surname>Maraganore</surname><given-names>D. M.</given-names></name></person-group><article-title>Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2011</year><volume>17</volume><issue>10</issue><fpage>730</fpage><lpage>736</lpage><pub-id pub-id-type="other">2-s2.0-81255127582</pub-id><pub-id pub-id-type="doi">10.1016/j.parkreldis.2011.07.001</pub-id><pub-id pub-id-type="pmid">21816655</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mata</surname><given-names>I. F.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Agarwal</surname><given-names>P.</given-names></name><etal/></person-group><article-title>SNCA variant associated with Parkinson disease and plasma <italic>&#x003b1;</italic>-synuclein level</article-title><source><italic>Archives of Neurology</italic></source><year>2010</year><volume>67</volume><issue>11</issue><fpage>1350</fpage><lpage>1356</lpage><pub-id pub-id-type="other">2-s2.0-78149489129</pub-id><pub-id pub-id-type="doi">10.1001/archneurol.2010.279</pub-id><pub-id pub-id-type="pmid">21060011</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><etal/></person-group><article-title>SNP rs7684318 of the <italic>&#x003b1;</italic>-synuclein gene is associated with Parkinson's disease in the Han Chinese population</article-title><source><italic>Brain Research</italic></source><year>2010</year><volume>1346</volume><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="other">2-s2.0-77955511002</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2010.05.069</pub-id><pub-id pub-id-type="pmid">20513365</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>F.-Y.</given-names></name><name><surname>Hu</surname><given-names>W.-B.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects</article-title><source><italic>Neuroscience Letters</italic></source><year>2010</year><volume>479</volume><issue>1</issue><fpage>31</fpage><lpage>33</lpage><pub-id pub-id-type="other">2-s2.0-77953704225</pub-id><pub-id pub-id-type="doi">10.1016/j.neulet.2010.05.022</pub-id><pub-id pub-id-type="pmid">20478361</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatto</surname><given-names>N. M.</given-names></name><name><surname>Rhodes</surname><given-names>S. L.</given-names></name><name><surname>Manthripragada</surname><given-names>A. D.</given-names></name><etal/></person-group><article-title>Alpha-synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease</article-title><source><italic>Neuroepidemiology</italic></source><year>2010</year><volume>35</volume><issue>3</issue><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1159/000315157</pub-id><pub-id pub-id-type="other">2-s2.0-77954885006</pub-id><pub-id pub-id-type="pmid">20664293</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>A.</given-names></name><name><surname>Vilari&#x000f1;o-G&#x000fc;ell</surname><given-names>C.</given-names></name><name><surname>Rajput</surname><given-names>M. L.</given-names></name><etal/></person-group><article-title>Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population</article-title><source><italic>Movement Disorders</italic></source><year>2009</year><volume>24</volume><issue>16</issue><fpage>2411</fpage><lpage>2414</lpage><pub-id pub-id-type="other">2-s2.0-73949104106</pub-id><pub-id pub-id-type="doi">10.1002/mds.22795</pub-id><pub-id pub-id-type="pmid">19890971</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>G. T.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><name><surname>Silburn</surname><given-names>P. A.</given-names></name><etal/></person-group><article-title>Do polymorphisms in the familial parkinsonism genes contribute to risk for sporadic Parkinson's disease?</article-title><source><italic>Movement Disorders</italic></source><year>2009</year><volume>24</volume><issue>6</issue><fpage>833</fpage><lpage>838</lpage><pub-id pub-id-type="other">2-s2.0-67651171518</pub-id><pub-id pub-id-type="doi">10.1002/mds.22214</pub-id><pub-id pub-id-type="pmid">19224617</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brighina</surname><given-names>L.</given-names></name><name><surname>Schneider</surname><given-names>N. K.</given-names></name><name><surname>Lesnick</surname><given-names>T. G.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein, alcohol use disorders, and Parkinson disease: a case-control study</article-title><source><italic>Parkinsonism and Related Disorders</italic></source><year>2009</year><volume>15</volume><issue>6</issue><fpage>430</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.11.011</pub-id><pub-id pub-id-type="other">2-s2.0-67449107209</pub-id><pub-id pub-id-type="pmid">19196539</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>D. M.</given-names></name><name><surname>Factor</surname><given-names>S. A.</given-names></name><name><surname>Samii</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Genetic association between <italic>&#x003b1;</italic>-synuclein and idiopathic Parkinson's disease</article-title><source><italic>American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics</italic></source><year>2008</year><volume>147</volume><issue>7</issue><fpage>1222</fpage><lpage>1230</lpage><pub-id pub-id-type="other">2-s2.0-55349111166</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.b.30758</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myhre</surname><given-names>R.</given-names></name><name><surname>Toft</surname><given-names>M.</given-names></name><name><surname>Kachergus</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population</article-title><source><italic>Acta Neurologica Scandinavica</italic></source><year>2008</year><volume>118</volume><issue>5</issue><fpage>320</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0404.2008.01019.x</pub-id><pub-id pub-id-type="other">2-s2.0-46949094193</pub-id><pub-id pub-id-type="pmid">18485051</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verbaan</surname><given-names>D.</given-names></name><name><surname>Boesveldt</surname><given-names>S.</given-names></name><name><surname>van Rooden</surname><given-names>S. M.</given-names></name><etal/></person-group><article-title>Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?</article-title><source><italic>Neurology</italic></source><year>2008</year><volume>71</volume><issue>23</issue><fpage>1877</fpage><lpage>1882</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000336651.48596.c7</pub-id><pub-id pub-id-type="other">2-s2.0-63849215406</pub-id><pub-id pub-id-type="pmid">19047559</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brighina</surname><given-names>L.</given-names></name><name><surname>Frigerio</surname><given-names>R.</given-names></name><name><surname>Schneider</surname><given-names>N. K.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein, pesticides, and Parkinson disease: a case-control study</article-title><source><italic>Neurology</italic></source><year>2008</year><volume>70</volume><issue>16</issue><fpage>1461</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000304049.31377.f2</pub-id><pub-id pub-id-type="other">2-s2.0-42049107065</pub-id><pub-id pub-id-type="pmid">18322262</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>O. A.</given-names></name><name><surname>Gosal</surname><given-names>D.</given-names></name><name><surname>Stone</surname><given-names>J. T.</given-names></name><etal/></person-group><article-title>Familial genes in sporadic disease: common variants of <italic>&#x003b1;</italic>-synuclein gene associate with Parkinson's disease</article-title><source><italic>Mechanisms of Ageing and Development</italic></source><year>2007</year><volume>128</volume><issue>5-6</issue><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2007.04.002</pub-id><pub-id pub-id-type="other">2-s2.0-34347383973</pub-id><pub-id pub-id-type="pmid">17531291</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>S.</given-names></name><name><surname>Hagenah</surname><given-names>J.</given-names></name><name><surname>Lincoln</surname><given-names>S.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein and Parkinson disease susceptibility</article-title><source><italic>Neurology</italic></source><year>2007</year><volume>69</volume><issue>18</issue><fpage>1745</fpage><lpage>1750</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000275524.15125.f4</pub-id><pub-id pub-id-type="other">2-s2.0-35848966980</pub-id><pub-id pub-id-type="pmid">17872362</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goris</surname><given-names>A.</given-names></name><name><surname>Williams-Gray</surname><given-names>C. H.</given-names></name><name><surname>Clark</surname><given-names>G. R.</given-names></name><etal/></person-group><article-title>Tau and <italic>&#x003b1;</italic>-synuclein in susceptibility to, and dementia in, Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>2007</year><volume>62</volume><issue>2</issue><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="other">2-s2.0-35148866228</pub-id><pub-id pub-id-type="doi">10.1002/ana.21192</pub-id><pub-id pub-id-type="pmid">17683088</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadjigeorgiou</surname><given-names>G. M.</given-names></name><name><surname>Xiromerisiou</surname><given-names>G.</given-names></name><name><surname>Gourbali</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Association of <italic>&#x003b1;</italic>-synuclein Rep1 polymorphism and Parkinson's disease: Influence of Rep1 on age at onset</article-title><source><italic>Movement Disorders</italic></source><year>2006</year><volume>21</volume><issue>4</issue><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1002/mds.20752</pub-id><pub-id pub-id-type="other">2-s2.0-33646249380</pub-id><pub-id pub-id-type="pmid">16250025</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>J. C.</given-names></name><name><surname>Fuchs</surname><given-names>J.</given-names></name><name><surname>Hofer</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Multiple regions of <italic>&#x003b1;</italic>-synuclein are associated with Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>2005</year><volume>57</volume><issue>4</issue><fpage>535</fpage><lpage>541</lpage><pub-id pub-id-type="other">2-s2.0-20144387092</pub-id><pub-id pub-id-type="doi">10.1002/ana.20438</pub-id><pub-id pub-id-type="pmid">15786467</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mamah</surname><given-names>C. E.</given-names></name><name><surname>Lesnick</surname><given-names>T. G.</given-names></name><name><surname>Lincoln</surname><given-names>S. J.</given-names></name><etal/></person-group><article-title>Interaction of <italic>&#x003b1;</italic>-synuclein and tau genotypes in Parkinson's disease</article-title><source><italic>Annals of Neurology</italic></source><year>2005</year><volume>57</volume><issue>3</issue><fpage>439</fpage><lpage>443</lpage><pub-id pub-id-type="other">2-s2.0-20044388324</pub-id><pub-id pub-id-type="doi">10.1002/ana.20387</pub-id><pub-id pub-id-type="pmid">15732111</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spadafora</surname><given-names>P.</given-names></name><name><surname>Annesi</surname><given-names>G.</given-names></name><name><surname>Pasqua</surname><given-names>A. A.</given-names></name><etal/></person-group><article-title>NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy</article-title><source><italic>Neuroscience Letters</italic></source><year>2003</year><volume>351</volume><issue>2</issue><fpage>75</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/S0304-3940(03)00859-0</pub-id><pub-id pub-id-type="other">2-s2.0-10744223645</pub-id><pub-id pub-id-type="pmid">14583385</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izumi</surname><given-names>Y.</given-names></name><name><surname>Morino</surname><given-names>H.</given-names></name><name><surname>Oda</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Genetic studies in Parkinson's disease with an <italic>&#x003b1;</italic>-synuclein/NACP gene polymorphism in Japan</article-title><source><italic>Neuroscience Letters</italic></source><year>2001</year><volume>300</volume><issue>2</issue><fpage>125</fpage><lpage>127</lpage><pub-id pub-id-type="other">2-s2.0-0035831303</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3940(01)01557-9</pub-id><pub-id pub-id-type="pmid">11207390</pub-id></element-citation></ref><ref id="B104"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>J.</given-names></name><name><surname>Tichopad</surname><given-names>A.</given-names></name><name><surname>Golub</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Genetic variability in the SNCA gene influences <italic>&#x003b1;</italic>-synuclein levels in the blood and brain</article-title><source><italic>FASEB Journal</italic></source><year>2008</year><volume>22</volume><issue>5</issue><fpage>1327</fpage><lpage>1334</lpage><pub-id pub-id-type="other">2-s2.0-43249120160</pub-id><pub-id pub-id-type="doi">10.1096/fj.07-9348com</pub-id><pub-id pub-id-type="pmid">18162487</pub-id></element-citation></ref><ref id="B84"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalls</surname><given-names>M. A.</given-names></name><name><surname>Pankratz</surname><given-names>N.</given-names></name><name><surname>Lill</surname><given-names>C. M.</given-names></name><etal/></person-group><article-title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease</article-title><source><italic>Nature Genetics</italic></source><year>2014</year><volume>46</volume><issue>9</issue><fpage>989</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1038/ng.3043</pub-id><pub-id pub-id-type="pmid">25064009</pub-id></element-citation></ref><ref id="B85"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>C. B.</given-names></name><name><surname>Tung</surname><given-names>J. Y.</given-names></name><name><surname>Dorfman</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Web-based genome-wide association study identifies two novel loci and a substantial genetic component for parkinson's disease</article-title><source><italic>PLoS Genetics</italic></source><year>2011</year><volume>7</volume><issue>6</issue><pub-id pub-id-type="other">2-s2.0-79959841853</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002141</pub-id><pub-id pub-id-type="publisher-id">e1002141</pub-id></element-citation></ref><ref id="B86"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Lei</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>F.</given-names></name></person-group><article-title>Meta-analysis of the association between alzheimer disease and variants in GAB2, PICALM, and SORL1</article-title><source><italic>Molecular Neurobiology</italic></source><year>2016</year><volume>53</volume><issue>9</issue><fpage>6501</fpage><lpage>6510</lpage><pub-id pub-id-type="doi">10.1007/s12035-015-9546-y</pub-id><pub-id pub-id-type="other">2-s2.0-84948422537</pub-id><pub-id pub-id-type="pmid">26611835</pub-id></element-citation></ref><ref id="B87"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>E. K.</given-names></name><name><surname>Kwok</surname><given-names>H. K.</given-names></name><name><surname>Tan</surname><given-names>L. C.</given-names></name><name><surname>Zhao</surname><given-names>W. T.</given-names></name><name><surname>Prakash</surname><given-names>K. M.</given-names></name><name><surname>Au</surname><given-names>W. L.</given-names></name><etal/></person-group><article-title>Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus</article-title><source><italic>Neurology</italic></source><year>2010</year><volume>75</volume><fpage>508</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f97048</pub-id><pub-id pub-id-type="pmid">20697102</pub-id></element-citation></ref><ref id="B88"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesage</surname><given-names>S.</given-names></name><name><surname>Brice</surname><given-names>A.</given-names></name></person-group><article-title>Parkinson's disease: from monogenic forms to genetic susceptibility factors</article-title><source><italic>Human Molecular Genetics</italic></source><year>2009</year><volume>18</volume><issue>R1</issue><fpage>R48</fpage><lpage>R59</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp012</pub-id><pub-id pub-id-type="other">2-s2.0-63149090431</pub-id><pub-id pub-id-type="pmid">19297401</pub-id></element-citation></ref><ref id="B89"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foo</surname><given-names>J. N.</given-names></name><name><surname>Chung</surname><given-names>S. J.</given-names></name><name><surname>Tan</surname><given-names>L. C.</given-names></name><etal/></person-group><article-title>Linking a genome-wide association study signal to a LRRK2 coding variant in Parkinson's disease</article-title><source><italic>Movement Disorders</italic></source><year>2016</year><volume>31</volume><issue>4</issue><fpage>484</fpage><lpage>487</lpage><pub-id pub-id-type="other">2-s2.0-84952334344</pub-id><pub-id pub-id-type="doi">10.1002/mds.26495</pub-id><pub-id pub-id-type="pmid">26687033</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maraganore</surname><given-names>D. M.</given-names></name><name><surname>de Andrade</surname><given-names>M.</given-names></name><name><surname>Elbaz</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Collaborative analysis of <italic>&#x003b1;</italic>-synuclein gene promoter variability and Parkinson disease</article-title><source><italic>The Journal of the American Medical Association</italic></source><year>2006</year><volume>296</volume><issue>6</issue><fpage>661</fpage><lpage>670</lpage><pub-id pub-id-type="doi">10.1001/jama.296.6.661</pub-id><pub-id pub-id-type="other">2-s2.0-33746869343</pub-id><pub-id pub-id-type="pmid">16896109</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venda</surname><given-names>L. L.</given-names></name><name><surname>Cragg</surname><given-names>S. J.</given-names></name><name><surname>Buchman</surname><given-names>V. L.</given-names></name><name><surname>Wade-Martins</surname><given-names>R.</given-names></name></person-group><article-title>
<italic>&#x003b1;</italic>-Synuclein and dopamine at the crossroads of Parkinson's disease</article-title><source><italic>Trends in Neurosciences</italic></source><year>2010</year><volume>33</volume><issue>12</issue><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2010.09.004</pub-id><pub-id pub-id-type="other">2-s2.0-78149466909</pub-id><pub-id pub-id-type="pmid">20961626</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firestone</surname><given-names>J. A.</given-names></name><name><surname>Smith-Weller</surname><given-names>T.</given-names></name><name><surname>Franklin</surname><given-names>G.</given-names></name><name><surname>Swanson</surname><given-names>P.</given-names></name><name><surname>Longstreth</surname><given-names>W. T.</given-names><suffix>Jr.</suffix></name><name><surname>Checkoway</surname><given-names>H.</given-names></name></person-group><article-title>Pesticides and risk of parkinson disease: a population-based case-control study</article-title><source><italic>Archives of Neurology</italic></source><year>2005</year><volume>62</volume><issue>1</issue><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1001/archneur.62.1.91</pub-id><pub-id pub-id-type="other">2-s2.0-12144251962</pub-id><pub-id pub-id-type="pmid">15642854</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semchuk</surname><given-names>K. M.</given-names></name><name><surname>Love</surname><given-names>E. J.</given-names></name><name><surname>Lee</surname><given-names>R. G.</given-names></name></person-group><article-title>Parkinson's disease and exposure to rural environmental factors: a population based case-control study</article-title><source><italic>Journal Canadien des Sciences Neurologiques</italic></source><year>1991</year><volume>18</volume><issue>3</issue><fpage>279</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1017/S0317167100031826</pub-id><pub-id pub-id-type="other">2-s2.0-0025936440</pub-id><pub-id pub-id-type="pmid">1913361</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allam</surname><given-names>M. F.</given-names></name><name><surname>Del Castillo</surname><given-names>A. S.</given-names></name><name><surname>Fern&#x000e1;ndez-Crehuet Navajas</surname><given-names>R.</given-names></name></person-group><article-title>Parkinson's disease risk factors: genetic, environmental, or both?</article-title><source><italic>Neurological Research</italic></source><year>2005</year><volume>27</volume><issue>2</issue><fpage>206</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1179/016164105X22057</pub-id><pub-id pub-id-type="other">2-s2.0-15244344237</pub-id><pub-id pub-id-type="pmid">15829184</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allam</surname><given-names>M. F.</given-names></name><name><surname>Campbell</surname><given-names>M. J.</given-names></name><name><surname>Hofman</surname><given-names>A.</given-names></name><name><surname>Del Castillo</surname><given-names>A. S.</given-names></name><name><surname>Navajas</surname><given-names>R. F.-C.</given-names></name></person-group><article-title>Smoking and Parkinson's disease: systematic review of prospective studies</article-title><source><italic>Movement Disorders</italic></source><year>2004</year><volume>19</volume><issue>6</issue><fpage>614</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/mds.20029</pub-id><pub-id pub-id-type="other">2-s2.0-4444230502</pub-id><pub-id pub-id-type="pmid">15197698</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name></person-group><article-title>Association between cigarette smoking and Parkinson's disease: a meta-analysis</article-title><source><italic>Archives of Gerontology and Geriatrics</italic></source><year>2015</year><volume>61</volume><issue>3</issue><fpage>510</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.archger.2015.08.004</pub-id><pub-id pub-id-type="pmid">26272284</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>J.</given-names></name><name><surname>Lunet</surname><given-names>N.</given-names></name><name><surname>Santos</surname><given-names>C.</given-names></name><name><surname>Santos</surname><given-names>J.</given-names></name><name><surname>Vaz-Carneiro</surname><given-names>A.</given-names></name></person-group><article-title>Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studiess</article-title><source><italic>Journal of Alzheimer's Disease</italic></source><year>2010</year><volume>20</volume><issue>supplement 1</issue><fpage>S221</fpage><lpage>S238</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-091525</pub-id><pub-id pub-id-type="other">2-s2.0-77956224302</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettiol</surname><given-names>S. S.</given-names></name><name><surname>Rose</surname><given-names>T. C.</given-names></name><name><surname>Hughes</surname><given-names>C. J.</given-names></name><name><surname>Smith</surname><given-names>L. A.</given-names></name></person-group><article-title>Alcohol consumption and Parkinson's disease risk: a review of recent findings</article-title><source><italic>Journal of Parkinson's Disease</italic></source><year>2015</year><volume>5</volume><issue>3</issue><fpage>425</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.3233/jpd-150533</pub-id><pub-id pub-id-type="other">2-s2.0-84941777411</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riederer</surname><given-names>P.</given-names></name><name><surname>Konradi</surname><given-names>C.</given-names></name><name><surname>Hebenstreit</surname><given-names>G.</given-names></name><name><surname>Youdim</surname><given-names>M.</given-names></name></person-group><article-title>Neurochemical perspectives to the function of monoamine oxidase</article-title><source><italic>Acta Neurologica Scandinavica</italic></source><year>1989</year><volume>80</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0404.1989.tb01781.x</pub-id><pub-id pub-id-type="pmid">2506728</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahi</surname><given-names>G. S.</given-names></name><name><surname>Moochhala</surname><given-names>S. M.</given-names></name></person-group><article-title>Smoking and Parkinson's disease&#x02014;a new perspective</article-title><source><italic>Reviews on Environmental Health</italic></source><year>1991</year><volume>9</volume><issue>3</issue><fpage>123</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1515/REVEH.1991.9.3.123</pub-id><pub-id pub-id-type="other">2-s2.0-0026336771</pub-id><pub-id pub-id-type="pmid">1792386</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savica</surname><given-names>R.</given-names></name><name><surname>Rocca</surname><given-names>W. A.</given-names></name><name><surname>Ahlskog</surname><given-names>J. E.</given-names></name></person-group><article-title>When does Parkinson disease start?</article-title><source><italic>Archives of Neurology</italic></source><year>2010</year><volume>67</volume><issue>7</issue><fpage>798</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2010.135</pub-id><pub-id pub-id-type="other">2-s2.0-77955016727</pub-id><pub-id pub-id-type="pmid">20625084</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrer</surname><given-names>M.</given-names></name><name><surname>Kachergus</surname><given-names>J.</given-names></name><name><surname>Forno</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Comparison of kindreds with Parkinsonism and <italic>&#x003b1;</italic>-synuclein genomic multiplications</article-title><source><italic>Annals of Neurology</italic></source><year>2004</year><volume>55</volume><issue>2</issue><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1002/ana.10846</pub-id><pub-id pub-id-type="other">2-s2.0-10744227740</pub-id><pub-id pub-id-type="pmid">14755720</pub-id></element-citation></ref><ref id="B105"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linnertz</surname><given-names>C.</given-names></name><name><surname>Saucier</surname><given-names>L.</given-names></name><name><surname>Ge</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Genetic regulation of <italic>&#x003b1;</italic>-synuclein mRNA expression in various human brain tissues</article-title><source><italic>PLoS ONE</italic></source><year>2009</year><volume>4</volume><issue>10</issue><pub-id pub-id-type="other">2-s2.0-70449428150</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007480</pub-id><pub-id pub-id-type="publisher-id">e7480</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Diagram illustrating the locations of the main SNPs in human SNCA gene reviewed in the present study: SNCA-REP1 (promoter region), rs2736990 (intron 4), rs356165 (3&#x02032; UTR), and rs356219, rs356220, and rs11931074 (3&#x02032; end). Black boxes indicate translated exons, grey boxes indicate untranslated regions, and the white line indicates introns.</p></caption><graphic xlink:href="PD2017-4318416.001"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characterization of the reviewed studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="left" colspan="1">Studies</th><th rowspan="2" align="center" colspan="1">Study ID</th><th rowspan="2" align="center" colspan="1">Country of participants</th><th colspan="2" align="center" rowspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Onset age</th></tr><tr><th align="center" rowspan="1" colspan="1">PD</th><th align="center" rowspan="1" colspan="1">Ctr</th><th align="center" rowspan="1" colspan="1">(mean &#x000b1; SD)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Davila-Ortiz de Montellano et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>]</td><td align="center" rowspan="1" colspan="1">Mexico</td><td align="center" rowspan="1" colspan="1">171</td><td align="center" rowspan="1" colspan="1">171</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Davis et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">418</td><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">60.4 &#x000b1; 11.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Garc&#x000ed;a et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B29" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1">Mexico</td><td align="center" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">56.2 &#x000b1; 14.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Shahmohammadibeni et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td><td align="center" rowspan="1" colspan="1">Iran</td><td align="center" rowspan="1" colspan="1">489</td><td align="center" rowspan="1" colspan="1">489</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">296</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Cheng et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">1053</td><td align="center" rowspan="1" colspan="1">1152</td><td align="center" rowspan="1" colspan="1">52.0 &#x000b1; 10.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Guella et al., 2016</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1">Multicentric<sup><italic>&#x02217;</italic></sup></td><td align="center" rowspan="1" colspan="1">1492</td><td align="center" rowspan="1" colspan="1">971</td><td align="center" rowspan="1" colspan="1">60.3 &#x000b1; 10.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen et al., 2015</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">218</td><td align="center" rowspan="1" colspan="1">110</td><td align="center" rowspan="1" colspan="1">60.6 &#x000b1; 07.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Huang et al., 2015</td><td align="center" rowspan="1" colspan="1">[<xref rid="B35" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1">China, Australia</td><td align="center" rowspan="1" colspan="1">402</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Han et al., 2015</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen et al., 2015</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">1276</td><td align="center" rowspan="1" colspan="1">846</td><td align="center" rowspan="1" colspan="1">56.3 &#x000b1; 11.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao et al., 2015</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">507</td><td align="center" rowspan="1" colspan="1">1330</td><td align="center" rowspan="1" colspan="1">68.3 &#x000b1; 5.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardo et al., 2014</td><td align="center" rowspan="1" colspan="1">[<xref rid="B39" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">752</td><td align="center" rowspan="1" colspan="1">489</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Guo et al., 2014</td><td align="center" rowspan="1" colspan="1">[<xref rid="B40" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">1011</td><td align="center" rowspan="1" colspan="1">721</td><td align="center" rowspan="1" colspan="1">56.6 &#x000b1; 11.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Pan et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B41" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">515</td><td align="center" rowspan="1" colspan="1">450</td><td align="center" rowspan="1" colspan="1">45.2 &#x000b1; 04.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Mata et al., 2014</td><td align="center" rowspan="1" colspan="1">[<xref rid="B42" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1191</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">59.46 &#x000b1; 10.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Markopoulou et al., 2014</td><td align="center" rowspan="1" colspan="1">[<xref rid="B43" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1098</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">62.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Emelyanov et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B44" ref-type="bibr">44</xref>]</td><td align="center" rowspan="1" colspan="1">Russia</td><td align="center" rowspan="1" colspan="1">244</td><td align="center" rowspan="1" colspan="1">308</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu-Chou et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">Taiwan</td><td align="center" rowspan="1" colspan="1">626</td><td align="center" rowspan="1" colspan="1">473</td><td align="center" rowspan="1" colspan="1">63.2 &#x000b1; 07.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Brockmann et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B46" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">Germany</td><td align="center" rowspan="1" colspan="1">1396</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">56.9 &#x000b1; 01.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Chung et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1098</td><td align="center" rowspan="1" colspan="1">1098</td><td align="center" rowspan="1" colspan="1">60.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Pihlstr&#x000f8;m et al., 2013</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>]</td><td align="center" rowspan="1" colspan="1">Norway and Sweden</td><td align="center" rowspan="1" colspan="1">1380</td><td align="center" rowspan="1" colspan="1">1295</td><td align="center" rowspan="1" colspan="1">59.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Heckman et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">426</td><td align="center" rowspan="1" colspan="1">769</td><td align="center" rowspan="1" colspan="1">62.0 &#x000b1; 12.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Ritz et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B50" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">232</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Schmitt et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B51" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">Germany</td><td align="center" rowspan="1" colspan="1">980</td><td align="center" rowspan="1" colspan="1">1005</td><td align="center" rowspan="1" colspan="1">59.4 &#x000b1; 12.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Miyake et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B52" ref-type="bibr">52</xref>]</td><td align="center" rowspan="1" colspan="1">Japan</td><td align="center" rowspan="1" colspan="1">229</td><td align="center" rowspan="1" colspan="1">357</td><td align="center" rowspan="1" colspan="1">65.7 &#x000b1; 08.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Pan et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B53" ref-type="bibr">53</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">403</td><td align="center" rowspan="1" colspan="1">315</td><td align="center" rowspan="1" colspan="1">57.8 &#x000b1; 08.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardo et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B54" ref-type="bibr">54</xref>]</td><td align="center" rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">727</td><td align="center" rowspan="1" colspan="1">480</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Gao et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B55" ref-type="bibr">55</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">584</td><td align="center" rowspan="1" colspan="1">1571</td><td align="center" rowspan="1" colspan="1">68.2 &#x000b1; 05.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Trotta et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">56</xref>]</td><td align="center" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">904</td><td align="center" rowspan="1" colspan="1">891</td><td align="center" rowspan="1" colspan="1">56.1 &#x000b1; 11.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Hu et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B57" ref-type="bibr">57</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">110</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1">56.7 &#x000b1; 10.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Botta-Orfilla et al., 2012</td><td align="center" rowspan="1" colspan="1">[<xref rid="B58" ref-type="bibr">58</xref>]</td><td align="center" rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Mata et al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B59" ref-type="bibr">59</xref>]</td><td align="center" rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">1445</td><td align="center" rowspan="1" colspan="1">1161</td><td align="center" rowspan="1" colspan="1">60.0 &#x000b1; 12.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Chung et al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B60" ref-type="bibr">60</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1103</td><td align="center" rowspan="1" colspan="1">1103</td><td align="center" rowspan="1" colspan="1">62.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Elbaz et al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B61" ref-type="bibr">61</xref>]</td><td align="center" rowspan="1" colspan="1">Multicentric<sup><italic>&#x02217;&#x02217;</italic></sup></td><td align="center" rowspan="1" colspan="1">5302</td><td align="center" rowspan="1" colspan="1">4161</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wider er al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B62" ref-type="bibr">62</xref>]</td><td align="center" rowspan="1" colspan="1">USA, Ireland, Norway</td><td align="center" rowspan="1" colspan="1">1020</td><td align="center" rowspan="1" colspan="1">1095</td><td align="center" rowspan="1" colspan="1">58.0 &#x000b1; 12.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Botta-Orfilla et al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B63" ref-type="bibr">63</xref>]</td><td align="center" rowspan="1" colspan="1">Spain</td><td align="center" rowspan="1" colspan="1">757</td><td align="center" rowspan="1" colspan="1">708</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Biernacka et al., 2011</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">64</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1098</td><td align="center" rowspan="1" colspan="1">1098</td><td align="center" rowspan="1" colspan="1">62.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Mata et al., 2010</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1956</td><td align="center" rowspan="1" colspan="1">2112</td><td align="center" rowspan="1" colspan="1">58.7 &#x000b1; 11.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Yu et al., 2010</td><td align="center" rowspan="1" colspan="1">[<xref rid="B66" ref-type="bibr">66</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">332</td><td align="center" rowspan="1" colspan="1">300</td><td align="center" rowspan="1" colspan="1">54.3 &#x000b1; 11.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hu et al., 2010</td><td align="center" rowspan="1" colspan="1">[<xref rid="B67" ref-type="bibr">67</xref>]</td><td align="center" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">330</td><td align="center" rowspan="1" colspan="1">300</td><td align="center" rowspan="1" colspan="1">52.6 &#x000b1; 11.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Gatto et al., 2010</td><td align="center" rowspan="1" colspan="1">[<xref rid="B68" ref-type="bibr">68</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">333</td><td align="center" rowspan="1" colspan="1">336</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rajput et al., 2009</td><td align="center" rowspan="1" colspan="1">[<xref rid="B69" ref-type="bibr">69</xref>]</td><td align="center" rowspan="1" colspan="1">Canada</td><td align="center" rowspan="1" colspan="1">452</td><td align="center" rowspan="1" colspan="1">245</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Sutherland et al., 2009</td><td align="center" rowspan="1" colspan="1">[<xref rid="B70" ref-type="bibr">70</xref>]</td><td align="center" rowspan="1" colspan="1">Australia</td><td align="center" rowspan="1" colspan="1">331</td><td align="center" rowspan="1" colspan="1">296</td><td align="center" rowspan="1" colspan="1">60.1 &#x000b1; 10.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Brighina et al., 2009</td><td align="center" rowspan="1" colspan="1">[<xref rid="B71" ref-type="bibr">71</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">893</td><td align="center" rowspan="1" colspan="1">893</td><td align="center" rowspan="1" colspan="1">62.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Kay et al., 2008</td><td align="center" rowspan="1" colspan="1">[<xref rid="B72" ref-type="bibr">72</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">1802</td><td align="center" rowspan="1" colspan="1">2192</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Myhre et al., 2008</td><td align="center" rowspan="1" colspan="1">[<xref rid="B73" ref-type="bibr">73</xref>]</td><td align="center" rowspan="1" colspan="1">Netherlands</td><td align="center" rowspan="1" colspan="1">236</td><td align="center" rowspan="1" colspan="1">236</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Verbaan et al., 2008</td><td align="center" rowspan="1" colspan="1">[<xref rid="B74" ref-type="bibr">74</xref>]</td><td align="center" rowspan="1" colspan="1">Netherlands</td><td align="center" rowspan="1" colspan="1">295</td><td align="center" rowspan="1" colspan="1">150</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Brighina et al., 2008</td><td align="center" rowspan="1" colspan="1">[<xref rid="B75" ref-type="bibr">75</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">833</td><td align="center" rowspan="1" colspan="1">833</td><td align="center" rowspan="1" colspan="1">61.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Ross et al., 2007</td><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>]</td><td align="center" rowspan="1" colspan="1">Ireland</td><td align="center" rowspan="1" colspan="1">186</td><td align="center" rowspan="1" colspan="1">186</td><td align="center" rowspan="1" colspan="1">50.0 &#x000b1; 11.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Winkler et al., 2007</td><td align="center" rowspan="1" colspan="1">[<xref rid="B77" ref-type="bibr">77</xref>]</td><td align="center" rowspan="1" colspan="1">Germany, Serbia</td><td align="center" rowspan="1" colspan="1">397</td><td align="center" rowspan="1" colspan="1">270</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Goris et al., 2007</td><td align="center" rowspan="1" colspan="1">[<xref rid="B78" ref-type="bibr">78</xref>]</td><td align="center" rowspan="1" colspan="1">UK</td><td align="center" rowspan="1" colspan="1">659</td><td align="center" rowspan="1" colspan="1">2176</td><td align="center" rowspan="1" colspan="1">63.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Hadjigeorgiou et al., 2006</td><td align="center" rowspan="1" colspan="1">[<xref rid="B79" ref-type="bibr">79</xref>]</td><td align="center" rowspan="1" colspan="1">Greece</td><td align="center" rowspan="1" colspan="1">178</td><td align="center" rowspan="1" colspan="1">186</td><td align="center" rowspan="1" colspan="1">63.3 &#x000b1; 9.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Mueller et al., 2005</td><td align="center" rowspan="1" colspan="1">[<xref rid="B80" ref-type="bibr">80</xref>]</td><td align="center" rowspan="1" colspan="1">Germany</td><td align="center" rowspan="1" colspan="1">669</td><td align="center" rowspan="1" colspan="1">1002</td><td align="center" rowspan="1" colspan="1">55.4 &#x000b1; 19.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Mamah et al., 2005</td><td align="center" rowspan="1" colspan="1">[<xref rid="B81" ref-type="bibr">81</xref>]</td><td align="center" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">557</td><td align="center" rowspan="1" colspan="1">557</td><td align="center" rowspan="1" colspan="1">63.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Spadafora et al., 2003</td><td align="center" rowspan="1" colspan="1">[<xref rid="B82" ref-type="bibr">82</xref>]</td><td align="center" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">186</td><td align="center" rowspan="1" colspan="1">182</td><td align="center" rowspan="1" colspan="1">&#x02014;</td></tr><tr><td align="left" rowspan="1" colspan="1">Izumi et al., 2001</td><td align="center" rowspan="1" colspan="1">[<xref rid="B83" ref-type="bibr">83</xref>]</td><td align="center" rowspan="1" colspan="1">Japan</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1">250</td><td align="center" rowspan="1" colspan="1">61.0 &#x000b1; 09.1</td></tr></tbody></table><table-wrap-foot><fn><p>ID: identification; PD: Parkinson's disease group; Ctr: control group; SD: standard deviation. <sup><italic>&#x02217;</italic></sup>The countries of origin of participants were New Zeeland, Canada, UK, and USA. <sup><italic>&#x02217;&#x02217;</italic></sup>The countries of origin of participants were Australia, France, Germany, Greece, Ireland, Italy, Norway, Poland, Sweden, and USA.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Single nucleotide polymorphisms (SNPs) in SNCA associated with Parkinson's disease.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variant</th><th align="center" rowspan="1" colspan="1">Region</th><th align="center" rowspan="1" colspan="1">Alleles</th><th align="center" rowspan="1" colspan="1">Studies<sup><italic>&#x02217;</italic></sup> with significant association with PD risk</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">REP1</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">259&#x02009;bp/261&#x02009;bp/263&#x02009;bp</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B81" ref-type="bibr">81</xref>] (&#x02191;) [<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B76" ref-type="bibr">76</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1372519</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2301134</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B76" ref-type="bibr">76</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2301135</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">C/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2619361</td><td align="center" rowspan="1" colspan="1">Promoter</td><td align="center" rowspan="1" colspan="1">A/C</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2619362</td><td align="center" rowspan="1" colspan="1">5&#x02032; region</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2619363</td><td align="center" rowspan="1" colspan="1">5&#x02032; region</td><td align="center" rowspan="1" colspan="1">G/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B77" ref-type="bibr">77</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2619364</td><td align="center" rowspan="1" colspan="1">5&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B77" ref-type="bibr">77</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2583988</td><td align="center" rowspan="1" colspan="1">5&#x02032; region</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B77" ref-type="bibr">77</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2119787</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B65" ref-type="bibr">65</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2197120</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">56</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2572324</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B65" ref-type="bibr">65</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2583959</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B64" ref-type="bibr">64</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2736990</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">T/C</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B60" ref-type="bibr">60</xref>] (&#x02191;) [<xref rid="B40" ref-type="bibr">40</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2737020</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2737029</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2737033</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B46" ref-type="bibr">46</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356164</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B76" ref-type="bibr">76</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356168</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356186</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B76" ref-type="bibr">76</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356203</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356204</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs3822086</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B37" ref-type="bibr">37</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs3857057</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs3857059</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs6848726</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B80" ref-type="bibr">80</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs7684318</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B66" ref-type="bibr">66</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs7689942</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs894278</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">G/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs1372520</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>] (&#x02191;) [<xref rid="B60" ref-type="bibr">60</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs10018362</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs2737012</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B49" ref-type="bibr">49</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs3756063</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B36" ref-type="bibr">36</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs3775423</td><td align="center" rowspan="1" colspan="1">Intron</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B64" ref-type="bibr">64</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356221</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B77" ref-type="bibr">77</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356165</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356182</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356218</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B60" ref-type="bibr">60</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356219</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">A/G</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B61" ref-type="bibr">61</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356220</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (&#x02191;) [<xref rid="B40" ref-type="bibr">40</xref>] (&#x02193;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs356225</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B33" ref-type="bibr">33</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs181489</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">C/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>] (&#x02191;)</td></tr><tr><td align="left" rowspan="1" colspan="1">rs11931074</td><td align="center" rowspan="1" colspan="1">3&#x02032; region</td><td align="center" rowspan="1" colspan="1">G/T</td><td align="center" rowspan="1" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B61" ref-type="bibr">61</xref>] (&#x02191;) [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B45" ref-type="bibr">45</xref>] (&#x02193;)</td></tr></tbody></table><table-wrap-foot><fn><p>SNP: single nucleotide polymorphism. <sup><italic>&#x02217;</italic></sup>See <xref ref-type="table" rid="tab1">Table 1</xref>. Arrows indicate whether the SNP increased (&#x02191;) or reduced (&#x02193;) PD susceptibility in each study, based on values of odds ratio and confidence intervals.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Association of environmental factors of PD with SNPs in SNCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Environmental factors</th><th align="center" rowspan="1" colspan="1">Studies<sup><italic>&#x02217;</italic></sup></th><th align="left" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B70" ref-type="bibr">70</xref>]</td><td align="left" rowspan="1" colspan="1">Individuals with GG-rs356219 and TT-rs356220 genotypes [<xref rid="B52" ref-type="bibr">52</xref>] and carriers of allele REP1-263&#x02009;bp [<xref rid="B47" ref-type="bibr">47</xref>] who never had smoked had a significantly increased risk of PD.</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Coffee intake</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B56" ref-type="bibr">56</xref>]</td><td align="left" rowspan="1" colspan="1">No SNPs were significantly associated with this factor.</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Pesticide exposure</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>]</td><td align="left" rowspan="1" colspan="1">Chung et al. [<xref rid="B47" ref-type="bibr">47</xref>] found a suggestive association between C-rs3775423 and pesticide exposure.</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Alcohol drinking</td><td align="center" rowspan="1" colspan="1">[<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B75" ref-type="bibr">75</xref>]</td><td align="left" rowspan="1" colspan="1">Brighina et al. [<xref rid="B75" ref-type="bibr">75</xref>] found independent effects to alcohol consumption and REP1-SNCA. Alcohol use was associated with a decreased PD risk.</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Head injury</td><td align="center" rowspan="1" colspan="1">[<xref rid="B38" ref-type="bibr">38</xref>]</td><td align="left" rowspan="1" colspan="1">Head injury increases PD risk, especially when it happens before the age of 30; no significant association with SNCA SNPs.</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup><italic>&#x02217;</italic></sup>See <xref ref-type="table" rid="tab1">Table 1</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Association of clinical aspects of PD and SNPs within SNCA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Studies<sup><italic>&#x02217;</italic></sup></th><th align="left" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age at onset</td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B79" ref-type="bibr">79</xref>]</td><td align="left" rowspan="1" colspan="1">SNPs were associated with earlier PD onset: REP1-263&#x02009;bp [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B79" ref-type="bibr">79</xref>]; C-rs2736990 [<xref rid="B41" ref-type="bibr">41</xref>]; G-rs894278 [<xref rid="B35" ref-type="bibr">35</xref>]; G-rs356219 [<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B58" ref-type="bibr">58</xref>]; G-rs356215 [<xref rid="B54" ref-type="bibr">54</xref>]</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Motor outcomes<sup>a</sup></td><td align="center" rowspan="1" colspan="1">[<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B74" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">Wang et al. [<xref rid="B31" ref-type="bibr">31</xref>] found a protective association between T-rs11931074 allele carriers and motor severity. Ritz et al. [<xref rid="B50" ref-type="bibr">50</xref>] found that REP1-263&#x02009;bp and G-rs356165 alleles increased the risk of faster decline of motor function, whereas Markopoulou et al. [<xref rid="B43" ref-type="bibr">43</xref>] demonstrated that REP1-263&#x02009;bp allele reduced the risk of developing motor impairments</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cognition outcomes<sup>b</sup></td><td align="center" rowspan="1" colspan="1">[<xref rid="B31" ref-type="bibr">31</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B78" ref-type="bibr">78</xref>]</td><td align="left" rowspan="1" colspan="1"> Markopoulou et al. [<xref rid="B43" ref-type="bibr">43</xref>] showed an increased risk of cognitive impairment in carriers of REP1-259&#x02009;bp allele. Guella et al. [<xref rid="B33" ref-type="bibr">33</xref>] found a significant association of C-rs10018362, T-rs7689942, and G-rs1348224 alleles with PD with dementia</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Anxiety and depression<sup>c</sup></td><td align="center" rowspan="1" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B74" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">No SNPs were significantly associated with symptoms</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Autonomic and sleep disorders<sup>d</sup></td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B74" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">No SNPs were significantly associated with symptoms</td></tr><tr><td colspan="3" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyposmia</td><td align="center" rowspan="1" colspan="1">[<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B74" ref-type="bibr">74</xref>]</td><td align="left" rowspan="1" colspan="1">In Chen et al.'s study [<xref rid="B34" ref-type="bibr">34</xref>], TT-rs11931074 genotype increased the risk of hyposmia in PD</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup><italic>&#x02217;</italic></sup>See <xref ref-type="table" rid="tab1">Table 1</xref>. <sup>a</sup>Questionnaires used: Unified Parkinson Disease Rating Scale-III and Hoehn and Yahr. <sup>b</sup>Questionnaires used: Mini-Mental State Examination, Frontal Assessment Battery, Montreal Cognitive Assessment, Scales for Outcomes in Parkinson's Disease Cognition, Hopkins Verbal Learning Test-Revised, Letter-Number Sequencing Test and Trail Making Test, Semantic and Phonemic Verbal Fluency Tests, and Benton Judgment of Line Orientation test. <sup>c</sup>Questionnaires used: Hamilton Rating Scale for Depression and Anxiety and Beck Depression Inventory. <sup>d</sup>Questionnaires used: REM Sleep Behavior Disorder Questionnaire, and Scales for Outcomes in Parkinson's Disease Autonomic, Nighttime Sleep, Daytime Sleepiness and Psychiatric Complications.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Interactions between alpha-synuclein levels and SNCA SNPs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">SNP</th><th align="center" rowspan="1" colspan="1">Risk allele</th><th align="left" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Hu et al. [<xref rid="B57" ref-type="bibr">57</xref>]</td><td align="center" rowspan="1" colspan="1">rs11931074</td><td align="center" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">The allele was associated with reduced levels of alpha-synuclein in serum</td></tr><tr><td align="center" rowspan="1" colspan="1">REP1</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="left" rowspan="1" colspan="1">Different alleles and genotypes did not influence levels of alpha-synuclein in serum</td></tr><tr><td colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mata et al. [<xref rid="B65" ref-type="bibr">65</xref>]</td><td align="center" rowspan="1" colspan="1">rs356219</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">CC genotype was correlated with increased levels of alpha-synuclein in plasma</td></tr><tr><td colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="3" align="left" colspan="1">Fuchs et al. [<xref rid="B104" ref-type="bibr">84</xref>]<sup>a</sup></td><td align="center" rowspan="1" colspan="1">rs2583988</td><td align="center" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">No correlation with alpha-synuclein mRNA or protein levels</td></tr><tr><td align="center" rowspan="1" colspan="1">REP1</td><td align="center" rowspan="1" colspan="1">261&#x02009;pb</td><td align="left" rowspan="1" colspan="1">256&#x02009;pb/256&#x02009;bp genotype was associated with lower alpha-synuclein levels assessed in blood samples; no effect in brain samples</td></tr><tr><td align="center" rowspan="1" colspan="1">rs356219</td><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">CT genotype correlated with higher SNCA mRNA levels in the substantia nigra and TT genotype showed higher SNCA mRNA levels in the cerebellum; no effect in blood samples</td></tr><tr><td colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="3" align="left" colspan="1">McCarthy et al. [<xref rid="B24" ref-type="bibr">24</xref>]<sup>a</sup></td><td align="center" rowspan="1" colspan="1">rs2736990&#x02009;</td><td align="center" rowspan="1" colspan="1">G&#x02009;</td><td rowspan="3" align="left" colspan="1">In the 3 SNPs, the GG genotype correlated with an increased expression ratio of SNCA112 mRNA in the frontal cortex</td></tr><tr><td align="center" rowspan="1" colspan="1">rs356165&#x02009;</td><td align="center" rowspan="1" colspan="1">G&#x02009;</td></tr><tr><td align="center" rowspan="1" colspan="1">rs356219&#x02009;</td><td align="center" rowspan="1" colspan="1">G&#x02009;</td></tr><tr><td colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="2" align="left" colspan="1">McCarthy et al. [<xref rid="B24" ref-type="bibr">24</xref>]<sup>a</sup></td><td align="center" rowspan="1" colspan="1">rs3857059&#x02009;</td><td align="center" rowspan="1" colspan="1">G&#x02009;</td><td rowspan="2" align="left" colspan="1">No correlation between genotypes and the ratio expression levels of SNCA112 mRNA</td></tr><tr><td align="center" rowspan="1" colspan="1">rs17016074</td><td align="center" rowspan="1" colspan="1">A</td></tr><tr><td colspan="4" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardo et al. [<xref rid="B39" ref-type="bibr">39</xref>]<sup>a</sup></td><td align="center" rowspan="1" colspan="1">rs356165&#x02009;<break/>rs11931074</td><td align="center" rowspan="1" colspan="1">G&#x02009;<break/>T</td><td align="left" rowspan="1" colspan="1">No significant differences for the SNCA isoform levels between the different genotypes assessed in brain tissues</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>a</sup>Postmortem studies.</p></fn></table-wrap-foot></table-wrap></floats-group></article>